This document provides a disease strategy for the management of an outbreak of sheep pox and goat pox in Australia. It summarizes the key information about the diseases, including that they are caused by viruses in the genus Capripoxvirus and primarily affect goats and sheep. Clinical signs include fever and lesions on the skin and in the mouth. The document outlines diagnostic criteria and treatment options, as well as principles of control and eradication that would be followed in an outbreak in Australia.
Telemedicine encompasses a variety of remote healthcare services delivered through technology. However, the legal landscape struggles to regulate telemedicine due to its complexity and interactions between healthcare, devices, data protection and other regulations. Telemedicine falls under provisions for cross-border healthcare services, but issues arise regarding professional qualifications and medical device regulations. Strict data protection laws also apply to health data processed and transmitted during telemedicine. As telemedicine continues advancing, companies must navigate these various legal requirements while regulatory frameworks work to better address this evolving area of healthcare.
Canadian code of practice for the care and handling of poultry Harm Kiezebrink
There is an increasing awareness that currently accepted moral standards of our society call for the prevention of any avoidable suffering. Domestication and artificial selection have made farm animals dependent on humans.
Consequently, according to the existing principles of ethics, humans must accept this dependence as a commitment for humane conduct toward domestic animals in all stages of their life.
Welfare codes like this Canadian Code of Practice are intended to encourage livestock producers, stock-keepers, handlers, transporters, and processors to adopt the highest standards of animal husbandry and handling.
The document describes contagious ecthyma, or orf, which is clinically diagnosed by the presence of eroded plaques on the teats and udder of sheep and around the mouths of suckling lambs. The lesions appear as erythema, vesicles or pustules that rupture and form thick scabs, leaving a horseshoe-shaped ring of small scabs surrounded by a wart-like granuloma. Treatment involves removing scabs and applying emollient cream before milking and an astringent solution after milking.
Pox lesions form on the faces of sheep after scabs develop from a highly contagious viral disease affecting sheep and goats. Lambs and kids under 4 months are highly susceptible and mortality rates are high. Clinical signs include fever, depression, anorexia, salivation, and pox lesions on unwooled areas of the skin like lips, eyelids, and nostrils. Treatment involves broad spectrum antibiotics, supportive care like IV fluids and analgesics, and local antiseptics for oral lesions. Vaccination with a live attenuated vaccine provides protection for 1 year.
1. Pseudocowpox is an infectious skin disease that only affects cattle. It is transmitted by insects and causes fever, skin nodules, swollen lymph nodes, and leg edema.
2. Clinical signs include fever over 40.1°C, firm skin nodules 0.5-5cm in diameter on the perineum, genitals, udder and body that later form dry scabs. There is also lymphadenitis and painful leg and chest edema.
3. Treatment is symptomatic with antibiotics, antipyretics, anti-inflammatories, and IV fluids. Vaccination of cattle over 6 months old with a live attenuated vaccine provides protection for up to 3 years.
This document lists various diseases that affect small ruminants like goats and sheep. It provides descriptions of clinical signs, lesions found during post-mortem examination, and histopathological or other diagnostic findings for each disease. Some of the diseases covered include caseous lymphadenitis, listeriosis, brucellosis, salmonellosis, dermatophilosis, mastitis, tuberculosis, pink eye, foot rot, and ringworm among others. Images are also provided to illustrate some of the characteristic lesions or clinical presentations of these diseases.
Telemedicine encompasses a variety of remote healthcare services delivered through technology. However, the legal landscape struggles to regulate telemedicine due to its complexity and interactions between healthcare, devices, data protection and other regulations. Telemedicine falls under provisions for cross-border healthcare services, but issues arise regarding professional qualifications and medical device regulations. Strict data protection laws also apply to health data processed and transmitted during telemedicine. As telemedicine continues advancing, companies must navigate these various legal requirements while regulatory frameworks work to better address this evolving area of healthcare.
Canadian code of practice for the care and handling of poultry Harm Kiezebrink
There is an increasing awareness that currently accepted moral standards of our society call for the prevention of any avoidable suffering. Domestication and artificial selection have made farm animals dependent on humans.
Consequently, according to the existing principles of ethics, humans must accept this dependence as a commitment for humane conduct toward domestic animals in all stages of their life.
Welfare codes like this Canadian Code of Practice are intended to encourage livestock producers, stock-keepers, handlers, transporters, and processors to adopt the highest standards of animal husbandry and handling.
The document describes contagious ecthyma, or orf, which is clinically diagnosed by the presence of eroded plaques on the teats and udder of sheep and around the mouths of suckling lambs. The lesions appear as erythema, vesicles or pustules that rupture and form thick scabs, leaving a horseshoe-shaped ring of small scabs surrounded by a wart-like granuloma. Treatment involves removing scabs and applying emollient cream before milking and an astringent solution after milking.
Pox lesions form on the faces of sheep after scabs develop from a highly contagious viral disease affecting sheep and goats. Lambs and kids under 4 months are highly susceptible and mortality rates are high. Clinical signs include fever, depression, anorexia, salivation, and pox lesions on unwooled areas of the skin like lips, eyelids, and nostrils. Treatment involves broad spectrum antibiotics, supportive care like IV fluids and analgesics, and local antiseptics for oral lesions. Vaccination with a live attenuated vaccine provides protection for 1 year.
1. Pseudocowpox is an infectious skin disease that only affects cattle. It is transmitted by insects and causes fever, skin nodules, swollen lymph nodes, and leg edema.
2. Clinical signs include fever over 40.1°C, firm skin nodules 0.5-5cm in diameter on the perineum, genitals, udder and body that later form dry scabs. There is also lymphadenitis and painful leg and chest edema.
3. Treatment is symptomatic with antibiotics, antipyretics, anti-inflammatories, and IV fluids. Vaccination of cattle over 6 months old with a live attenuated vaccine provides protection for up to 3 years.
This document lists various diseases that affect small ruminants like goats and sheep. It provides descriptions of clinical signs, lesions found during post-mortem examination, and histopathological or other diagnostic findings for each disease. Some of the diseases covered include caseous lymphadenitis, listeriosis, brucellosis, salmonellosis, dermatophilosis, mastitis, tuberculosis, pink eye, foot rot, and ringworm among others. Images are also provided to illustrate some of the characteristic lesions or clinical presentations of these diseases.
Explanation of the body condition scale for dairy cattle, including numerous pictures of cows at different scores.
Animations in the presentation can be viewed by downloading the file.
The document discusses a study on the relationship between hygiene scores and subclinical mastitis in dairy cows. The study aimed to determine if poor hygiene, assessed via hygiene scoring of the udder, lower legs, and upper legs/flank, was correlated with higher rates of subclinical mastitis. The results found good hygiene scores in the small sample of cows studied, which all had no signs of subclinical mastitis based on California Mastitis Tests. However, the small sample size prevented definitive statistical analysis, so no relationship could be confirmed. Larger multi-farm studies over longer periods were recommended to further explore the potential relationship between hygiene and subclinical mastitis.
Mastitis in dairy cows and how it affects lifetime productivityAntonella Strömberg
Mastitis is the second most common reason for culling dairy cows and greatly impacts farm productivity and costs. Mastitis can be either clinical (visible) or subclinical (no visible signs), with subclinical cases accounting for 80% of infections. Preventing mastitis requires maintaining hygiene during milking, keeping equipment clean, providing a dry environment, monitoring cow health, and treating clinical cases promptly while limiting antibiotic use to reduce resistance. The key is reducing bacterial exposure and identifying and culling chronically infected cows to improve herd health and milk quality long-term.
Mastitis is an inflammatory disease of the mammary gland caused mainly by bacterial infections entering through the teat canal. It can be clinical or subclinical and affects milk production and quality. Diagnosis involves somatic cell counts, California Mastitis Test, and culture of milk samples. Treatment depends on causative organism but includes intramammary antibiotics and supportive therapies. Prevention focuses on proper milking hygiene, teat dipping, dry cow therapy, and culling chronically infected cows. Unaddressed mastitis poses economic losses to dairy operations.
Mastitis is an inflammation of the breast tissue, usually caused by blocked milk ducts or bacterial infection. Symptoms include breast pain, swelling, redness, and fever. Staphylococcus aureus is a common cause of infectious mastitis. Treatment involves antibiotics, analgesics, breast emptying/feeding, and drainage of abscesses. Supportive breastfeeding is important for recovery during lactation-associated mastitis.
Poxviruses are a family of viruses that can infect both vertebrates and invertebrates. The most notable member is the smallpox virus. Four genera may infect humans, including orthopox (which includes smallpox, cowpox, and monkeypox viruses) and molluscipox (which causes molluscum contagiosum). Poxviruses have complex brick-shaped particles that contain double-stranded DNA and replicate in the cytoplasm of infected cells. Notable human infections include cowpox, molluscum contagiosum, monkeypox, and smallpox.
Bovine mastitis is an inflammation of the udder in dairy cows that can range from subclinical to clinical. It is primarily caused by bacterial infections that enter through the teat canal. Mastitis has significant economic impacts on dairy farms through reduced milk production and quality. Proper milking procedures and hygiene are critical to mastitis prevention. A 10 step program including teat dipping, equipment maintenance, and monitoring somatic cell counts can help control mastitis on dairy farms.
This document describes the development of an ear tag sensor device to remotely monitor the behavior and health status of individual pigs on farms. The sensor device contains temperature, motion, and sound sensors to collect data on external temperature, activity, vocalizations, and head movements. This behavioral data would then be used to develop machine learning models to classify normal and abnormal behaviors that could indicate issues like lameness, distress, or illness. Adoption of this technology by farmers could allow early detection of health problems in pigs and more efficient farm management.
This document describes the development of a sensor board that can be attached to pig ear tags to remotely monitor behavioral indicators of pig health and welfare. The sensor board measures external temperature, movement, vocalizations, and other data. This data will be used to develop machine learning models to classify pig behaviors and identify issues. Factors that influence adoption of this technology by farmers are also discussed.
The document discusses livestock disease threats in the UK. It notes that increased global population and meat consumption will lead to growth in the livestock sector and increased risk of disease. Current UK policy focuses on both preventing diseases from entering the country and controlling outbreaks if they occur. Key prevention methods include surveillance, controlling diseases at their source, enforcing biosecurity measures on farms, improving animal traceability, and restricting imports and trade.
This document describes a study protocol that aims to assess and improve the integration of acetylcholinesterase (AChE) monitoring into rural health clinics in Australia. The study will measure AChE activity and pesticide use in 50 agricultural workers routinely exposed to organophosphate pesticides and 30 non-farmers over 10 weeks. Baseline health and pesticide use data will be collected. Participants will have their AChE levels tested every 3 weeks using a finger prick. They will receive feedback and counselling on their levels. The study aims to provide evidence for integrating AChE monitoring into health clinics to identify pesticide exposure, improve safety practices, and quantify exposure risks for farmers and their families.
Animal Health And Disease Monitoring In The AbattoirGina Rizzo
Ed G.M. van Klink, Pia Gjertsen Prestmo, and Andrew Grist discuss how abattoirs can be used to monitor animal health and disease. They note that all slaughter animals are inspected for diseases that could impact public health, animal health, or welfare. Abattoirs provide a cost-effective way to monitor for notifiable diseases, zoonotic diseases, and issues affecting animal husbandry through inspection and sampling. Specifically, abattoirs are important for surveillance programs demonstrating freedom from diseases like bovine tuberculosis, classical swine fever, and Aujeszky's disease. However, the authors argue that abattoir data is currently underutilized and could provide more
Current Situation and Government Efforts to Fight Avian Influenza - CRS Post ...Tata Naipospos
This document discusses avian influenza in Indonesia. It provides statistics on Indonesia's poultry population and production systems. Smallholder backyard farms account for 20% of production while commercial farms make up the remaining 80%. Avian influenza has been confirmed in 29 out of 33 Indonesian provinces. The government's national strategic plan aims to control avian influenza at its source in animals through culling, compensation, vaccines, and improved biosecurity. The plan also focuses on risk communication and strengthening human pandemic preparedness.
VS FMD Strategy - Beth Lautner, DVM MS, USDA, APHIS, VS, from the 2014 NIAA Annual Conference titled 'The Precautionary Principle: How Agriculture Will Thrive', March 31 - April 2, 2014, Omaha, NE, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2014_niaa_how_animal_agriculture_will_thrive
Bravecto (fluralaner) chewable tablets have been thoroughly evaluated in multiple countries and are approved as a safe and effective flea, tick and mite treatment for dogs Abstract — Bravecto (fluralaner) is thoroughly tested to international safety standards for veterinary drugs, meeting approval requirements for over 70 countries. This valuable antiparasite (fleas, ticks and mites) treatment contributes to the health of millions of dogs and promotes dog health worldwide by protecting them against dangerous parasite infestations that are known to lead to pathogen transmission, blood loss, local irritation, and skin allergies. In 2017, the European Medicines Agency (EMA) completed an in depth targeted review of all reported adverse events (ADE) related to various potential disorders and confirmed the positive benefit-risk profile of Bravecto. Official records that monitor adverse events are often available online and these reports can be easily misunderstood by people unfamiliar with the procedures and how to interpret monitoring information. For example, many people do not know that the FDA advises " For any given ADE report, there is no certainty that the reported drug caused the adverse event. " This means that the cause of a problem reported to this agency has not been determined, and this is typical of drug use reports. Multiple communications from individual dog and cat owners provided photographs showing how their pet has dramatically improved with the help of fluralaner treatment.
This document provides guidelines for the humane handling and transport of turkeys. It defines animal welfare, outlines turkey behavior, and describes best practices for catching, herding, loading and transporting turkeys to minimize stress and injuries. Key aspects include moving turkeys quietly, avoiding yelling, using appropriate lighting, checking birds for injuries before transport, and following loading density guidelines based on weather conditions. Completing a catching report evaluates welfare and ensures humane treatment.
Livestock are farm animals who are raised to generate profit. They are used for the commodities such as meat, eggs, milk, fur, leather and wool. Livestock animals usually distribute in remote areas, with relatively poor condition of disease diagnosis. Generally, it is difficult to carry out disease diagnosis rapidly and accurately.
Livestock diseases often pose a risk to public health and even affects the economy at large extent as we are quite dependent on the essential commodities we procure from the livestock. It is necessary to detect the disease outcome in the livestock to take the precautionary measures in order to avoid spread amongst them. So, there is a need for a system which can help in predicting the diseases among livestock on the basis of symptoms and suggest the precautionary measures to be taken with respect to the disease predicted. Our proposed system will predict the livestock (Cow, Sheep and Goat) disease using SVC (Support Vector Classifier) multi-class classification algorithm based on the symptoms and also provide the precautionary measures on the basis of disease predicted. There are some diseases which can prove to be fatal. So, our system will also alert the livestock owner if the predicted disease may cause a sudden death.
EFSA AHAW report on monitoring procedures at poultry slaughterhousesHarm Kiezebrink
The EFSA Panel on Animal Health and Welfare (AHAW) was asked to deliver scientific opinions on monitoring procedures at slaughterhouses for different animal species, stunning methods and slaughter without stunning. AHAW agreed that, although it is traditional to look for outcomes of unconsciousness in poultry following stunning, the risk of poor welfare can be detected better if bird welfare monitoring is focused on detecting consciousness, i.e. ineffective stunning or recovery of consciousness.
Therefore, the indicators were phrased neutrally (e.g. corneal reflex) and the outcomes were phrased either suggesting unconsciousness (e.g. absence of corneal reflex) or suggesting consciousness (e.g. presence of corneal reflex). This approach is commonly used in animal health studies (e.g. testing for the presence of a disease) but very new to animal welfare monitoring in slaughterhouses.
A toolbox of selected indicators is proposed to check for signs of consciousness in poultry after stunning with waterbaths or gas mixtures; a different toolbox of indicators is proposed for confirming death of the birds following slaughter without stunning.
This document provides guidelines for health and hygiene for ostriches farmed commercially. It discusses some common diseases that can affect ostriches, including Newcastle disease, salmonellosis, and clostridiosis. It emphasizes the importance of vaccination protocols and biosecurity measures to prevent disease outbreaks. Specific recommendations are provided for vaccination schedules and practices. Maintaining strict hygiene, isolating sick birds, and disinfecting equipment and facilities can help control the spread of pathogens. Further research is needed on diseases that may affect ostriches in Pakistan.
Henry Too presented on pig production in Asia and experiences with Circovac®. Pig farming ranges from small backyard operations to commercial farms. Circovac® is registered for use in several Asian countries and has been shown in trials to significantly reduce mortality and PCVD-specific mortality, improve growth rates, reduce time to slaughter, and decrease viral shedding compared to non-vaccinated pigs. The results demonstrate Circovac® is effective at controlling PCV2 infections across the whole herd through sow or piglet vaccination.
Washington Global Health Alliance Discovery Series
Supamit Chinsuttiwat
May 22, 2008
'Response to Avian Influenza and Preparedness for Pandemic Influenza: Thailand's Experience'
Explanation of the body condition scale for dairy cattle, including numerous pictures of cows at different scores.
Animations in the presentation can be viewed by downloading the file.
The document discusses a study on the relationship between hygiene scores and subclinical mastitis in dairy cows. The study aimed to determine if poor hygiene, assessed via hygiene scoring of the udder, lower legs, and upper legs/flank, was correlated with higher rates of subclinical mastitis. The results found good hygiene scores in the small sample of cows studied, which all had no signs of subclinical mastitis based on California Mastitis Tests. However, the small sample size prevented definitive statistical analysis, so no relationship could be confirmed. Larger multi-farm studies over longer periods were recommended to further explore the potential relationship between hygiene and subclinical mastitis.
Mastitis in dairy cows and how it affects lifetime productivityAntonella Strömberg
Mastitis is the second most common reason for culling dairy cows and greatly impacts farm productivity and costs. Mastitis can be either clinical (visible) or subclinical (no visible signs), with subclinical cases accounting for 80% of infections. Preventing mastitis requires maintaining hygiene during milking, keeping equipment clean, providing a dry environment, monitoring cow health, and treating clinical cases promptly while limiting antibiotic use to reduce resistance. The key is reducing bacterial exposure and identifying and culling chronically infected cows to improve herd health and milk quality long-term.
Mastitis is an inflammatory disease of the mammary gland caused mainly by bacterial infections entering through the teat canal. It can be clinical or subclinical and affects milk production and quality. Diagnosis involves somatic cell counts, California Mastitis Test, and culture of milk samples. Treatment depends on causative organism but includes intramammary antibiotics and supportive therapies. Prevention focuses on proper milking hygiene, teat dipping, dry cow therapy, and culling chronically infected cows. Unaddressed mastitis poses economic losses to dairy operations.
Mastitis is an inflammation of the breast tissue, usually caused by blocked milk ducts or bacterial infection. Symptoms include breast pain, swelling, redness, and fever. Staphylococcus aureus is a common cause of infectious mastitis. Treatment involves antibiotics, analgesics, breast emptying/feeding, and drainage of abscesses. Supportive breastfeeding is important for recovery during lactation-associated mastitis.
Poxviruses are a family of viruses that can infect both vertebrates and invertebrates. The most notable member is the smallpox virus. Four genera may infect humans, including orthopox (which includes smallpox, cowpox, and monkeypox viruses) and molluscipox (which causes molluscum contagiosum). Poxviruses have complex brick-shaped particles that contain double-stranded DNA and replicate in the cytoplasm of infected cells. Notable human infections include cowpox, molluscum contagiosum, monkeypox, and smallpox.
Bovine mastitis is an inflammation of the udder in dairy cows that can range from subclinical to clinical. It is primarily caused by bacterial infections that enter through the teat canal. Mastitis has significant economic impacts on dairy farms through reduced milk production and quality. Proper milking procedures and hygiene are critical to mastitis prevention. A 10 step program including teat dipping, equipment maintenance, and monitoring somatic cell counts can help control mastitis on dairy farms.
This document describes the development of an ear tag sensor device to remotely monitor the behavior and health status of individual pigs on farms. The sensor device contains temperature, motion, and sound sensors to collect data on external temperature, activity, vocalizations, and head movements. This behavioral data would then be used to develop machine learning models to classify normal and abnormal behaviors that could indicate issues like lameness, distress, or illness. Adoption of this technology by farmers could allow early detection of health problems in pigs and more efficient farm management.
This document describes the development of a sensor board that can be attached to pig ear tags to remotely monitor behavioral indicators of pig health and welfare. The sensor board measures external temperature, movement, vocalizations, and other data. This data will be used to develop machine learning models to classify pig behaviors and identify issues. Factors that influence adoption of this technology by farmers are also discussed.
The document discusses livestock disease threats in the UK. It notes that increased global population and meat consumption will lead to growth in the livestock sector and increased risk of disease. Current UK policy focuses on both preventing diseases from entering the country and controlling outbreaks if they occur. Key prevention methods include surveillance, controlling diseases at their source, enforcing biosecurity measures on farms, improving animal traceability, and restricting imports and trade.
This document describes a study protocol that aims to assess and improve the integration of acetylcholinesterase (AChE) monitoring into rural health clinics in Australia. The study will measure AChE activity and pesticide use in 50 agricultural workers routinely exposed to organophosphate pesticides and 30 non-farmers over 10 weeks. Baseline health and pesticide use data will be collected. Participants will have their AChE levels tested every 3 weeks using a finger prick. They will receive feedback and counselling on their levels. The study aims to provide evidence for integrating AChE monitoring into health clinics to identify pesticide exposure, improve safety practices, and quantify exposure risks for farmers and their families.
Animal Health And Disease Monitoring In The AbattoirGina Rizzo
Ed G.M. van Klink, Pia Gjertsen Prestmo, and Andrew Grist discuss how abattoirs can be used to monitor animal health and disease. They note that all slaughter animals are inspected for diseases that could impact public health, animal health, or welfare. Abattoirs provide a cost-effective way to monitor for notifiable diseases, zoonotic diseases, and issues affecting animal husbandry through inspection and sampling. Specifically, abattoirs are important for surveillance programs demonstrating freedom from diseases like bovine tuberculosis, classical swine fever, and Aujeszky's disease. However, the authors argue that abattoir data is currently underutilized and could provide more
Current Situation and Government Efforts to Fight Avian Influenza - CRS Post ...Tata Naipospos
This document discusses avian influenza in Indonesia. It provides statistics on Indonesia's poultry population and production systems. Smallholder backyard farms account for 20% of production while commercial farms make up the remaining 80%. Avian influenza has been confirmed in 29 out of 33 Indonesian provinces. The government's national strategic plan aims to control avian influenza at its source in animals through culling, compensation, vaccines, and improved biosecurity. The plan also focuses on risk communication and strengthening human pandemic preparedness.
VS FMD Strategy - Beth Lautner, DVM MS, USDA, APHIS, VS, from the 2014 NIAA Annual Conference titled 'The Precautionary Principle: How Agriculture Will Thrive', March 31 - April 2, 2014, Omaha, NE, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2014_niaa_how_animal_agriculture_will_thrive
Bravecto (fluralaner) chewable tablets have been thoroughly evaluated in multiple countries and are approved as a safe and effective flea, tick and mite treatment for dogs Abstract — Bravecto (fluralaner) is thoroughly tested to international safety standards for veterinary drugs, meeting approval requirements for over 70 countries. This valuable antiparasite (fleas, ticks and mites) treatment contributes to the health of millions of dogs and promotes dog health worldwide by protecting them against dangerous parasite infestations that are known to lead to pathogen transmission, blood loss, local irritation, and skin allergies. In 2017, the European Medicines Agency (EMA) completed an in depth targeted review of all reported adverse events (ADE) related to various potential disorders and confirmed the positive benefit-risk profile of Bravecto. Official records that monitor adverse events are often available online and these reports can be easily misunderstood by people unfamiliar with the procedures and how to interpret monitoring information. For example, many people do not know that the FDA advises " For any given ADE report, there is no certainty that the reported drug caused the adverse event. " This means that the cause of a problem reported to this agency has not been determined, and this is typical of drug use reports. Multiple communications from individual dog and cat owners provided photographs showing how their pet has dramatically improved with the help of fluralaner treatment.
This document provides guidelines for the humane handling and transport of turkeys. It defines animal welfare, outlines turkey behavior, and describes best practices for catching, herding, loading and transporting turkeys to minimize stress and injuries. Key aspects include moving turkeys quietly, avoiding yelling, using appropriate lighting, checking birds for injuries before transport, and following loading density guidelines based on weather conditions. Completing a catching report evaluates welfare and ensures humane treatment.
Livestock are farm animals who are raised to generate profit. They are used for the commodities such as meat, eggs, milk, fur, leather and wool. Livestock animals usually distribute in remote areas, with relatively poor condition of disease diagnosis. Generally, it is difficult to carry out disease diagnosis rapidly and accurately.
Livestock diseases often pose a risk to public health and even affects the economy at large extent as we are quite dependent on the essential commodities we procure from the livestock. It is necessary to detect the disease outcome in the livestock to take the precautionary measures in order to avoid spread amongst them. So, there is a need for a system which can help in predicting the diseases among livestock on the basis of symptoms and suggest the precautionary measures to be taken with respect to the disease predicted. Our proposed system will predict the livestock (Cow, Sheep and Goat) disease using SVC (Support Vector Classifier) multi-class classification algorithm based on the symptoms and also provide the precautionary measures on the basis of disease predicted. There are some diseases which can prove to be fatal. So, our system will also alert the livestock owner if the predicted disease may cause a sudden death.
EFSA AHAW report on monitoring procedures at poultry slaughterhousesHarm Kiezebrink
The EFSA Panel on Animal Health and Welfare (AHAW) was asked to deliver scientific opinions on monitoring procedures at slaughterhouses for different animal species, stunning methods and slaughter without stunning. AHAW agreed that, although it is traditional to look for outcomes of unconsciousness in poultry following stunning, the risk of poor welfare can be detected better if bird welfare monitoring is focused on detecting consciousness, i.e. ineffective stunning or recovery of consciousness.
Therefore, the indicators were phrased neutrally (e.g. corneal reflex) and the outcomes were phrased either suggesting unconsciousness (e.g. absence of corneal reflex) or suggesting consciousness (e.g. presence of corneal reflex). This approach is commonly used in animal health studies (e.g. testing for the presence of a disease) but very new to animal welfare monitoring in slaughterhouses.
A toolbox of selected indicators is proposed to check for signs of consciousness in poultry after stunning with waterbaths or gas mixtures; a different toolbox of indicators is proposed for confirming death of the birds following slaughter without stunning.
This document provides guidelines for health and hygiene for ostriches farmed commercially. It discusses some common diseases that can affect ostriches, including Newcastle disease, salmonellosis, and clostridiosis. It emphasizes the importance of vaccination protocols and biosecurity measures to prevent disease outbreaks. Specific recommendations are provided for vaccination schedules and practices. Maintaining strict hygiene, isolating sick birds, and disinfecting equipment and facilities can help control the spread of pathogens. Further research is needed on diseases that may affect ostriches in Pakistan.
Henry Too presented on pig production in Asia and experiences with Circovac®. Pig farming ranges from small backyard operations to commercial farms. Circovac® is registered for use in several Asian countries and has been shown in trials to significantly reduce mortality and PCVD-specific mortality, improve growth rates, reduce time to slaughter, and decrease viral shedding compared to non-vaccinated pigs. The results demonstrate Circovac® is effective at controlling PCV2 infections across the whole herd through sow or piglet vaccination.
Washington Global Health Alliance Discovery Series
Supamit Chinsuttiwat
May 22, 2008
'Response to Avian Influenza and Preparedness for Pandemic Influenza: Thailand's Experience'
Automatic Estrus Detection System for Dairy Animalsidescitation
This paper deals with the new aid for detection of
Estrus (Heat) in dairy animals. As dairy Technology is
developing day by day, therefore reproductive performance of
dairy animals is major concern in dairy industry. This
Reproductive performance of dairy animals requires accurate
and regular Estrus detection. Estrus is nothing but a
behavioural symptom in mammals which indicate that female
is mated close to the ovulation. That’s why Timely detection
of estrus is the only solution to increase the fertility rate in
dairy animals. Failure to detect animal in estrus and breeding
animals which are not in estrus result in economic loss for
the owner because of extended calving interval and additional
semen expenses. Accurate Estrus detection gives idea about
proper timing of Artificial Insemination. So Estrus detection
is the key solution for effective growth in dairy technology.
During estrus period animal shows mounting behaviour,
increased physical activity and vaginal temperature of animal
is increased. So, in proposed technology, for the very first
time all these three signs are sensed by three sensors. The
signal from the sensors are given to the micro-controller, then
micro-controller process the data, display the data on LCD
screen as well as transfer all the data wirelessly to the Personal
computer (PC). PC runs a software module which display all
the data i.e. Animal name, number of mounting, physical
activity and vaginal temperature.
Dr. Tim Snider - PEDV-Warning Shot for National Biosecurity and Foreign Anima...John Blue
PEDV-Warning Shot for National Biosecurity and Foreign Animal Disease Preparedness and Response - Dr. Tim Snider, Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, from the 2013 Allen D. Leman Swine Conference, September 14-17, 2013, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2013-leman-swine-conference-material
The document discusses India's livestock population statistics and role of the livestock sector in the Indian economy. It notes that India has the largest populations of buffalo, cattle, sheep, goats, and is a top producer of milk, beef, and goat milk globally. However, it also faces challenges like low milk production per cow compared to global standards. The document outlines various animal disease control programs in India addressing diseases like foot and mouth, rinderpest, and peste des petits ruminants. It provides statistics on budgets for these programs and their goals of disease surveillance and vaccination efforts.
Animal Disease Control Programs in India.pptBhoj Raj Singh
India is a hyperendemic country for many animal diseases and zoonotic diseases. Every year billions of rupees are spent on disease control, surveillance, monitoring, and vaccination against vaccine-preventable diseases. However, due to the failure of most animal disease control programs for one or other reasons India directly losses about 20 and 25 thousand crores annually due to endemicity of FMD & brucellosis, respectively. The presentation describes the pros and cons of different ongoing disease control programs going on in India.
One Health studies of pig associated zoonoses in smallholder pig production i...ILRI
Poster by P. Inthavong, B. Khamlome, V. Solomon, K. Vongxay, J. Allen, A. Okello, J. Conlan, J. Gilbert and F. Unger presented at the 4th International One Health Congress and 6th Biennial Congress of the International Association for Ecology and Health (One Health EcoHealth 2016), Melbourne, Australia, 3–7 December 2016.
Cameroon animal health system & emergency management systemarsene meba
Cameroon's animal health system and emergency management program were presented. Key points included:
1. Cameroon has a national animal health emergency plan and organizational chart in place but gaps remain in fully integrating sectors and establishing regional emergency operation centers.
2. Emergency categories include natural disasters, diseases, accidents, and social/political risks. Emergencies are coordinated by various ministries depending on the type and level.
3. Goals for the fellowship include strengthening Cameroon's animal health emergency management program by developing standard operating procedures, an incident action plan, and an emergency management plan.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Sheep pox
1. AU S T R AL I AN V E T E R I N AR Y E M E R GE N C Y P L AN
AUSVETPLAN
Disease Strategy
Sheep pox and goat pox
Version 3.1, 2011
AUSVETPLAN is a series of technical response plans that describe the proposed
Australian approach to an emergency animal disease incident. The documents provide
guidance based on sound analysis, linking policy, strategies, implementation,
coordination and emergency-management plans.
Primary Industries Ministerial Council
3. Filename: SGP3.1-18FINAL(12Aug11).doc
Preface
This disease strategy for the management of an outbreak of sheep pox and goat pox
(SGP) is an integral part of the Australian Veterinary Emergency Plan, or
AUSVETPLAN (Edition 3). AUSVETPLAN structures and functions are described in
the AUSVETPLAN Summary Document. The disease strategy provides information
about the diseases (Section 1); the relevant risk factors and their treatment, and the
options for the management of a disease outbreak depending on the circumstances
(Section 2); and the policy that will be adopted in the case of an outbreak (Sections 3
and 4).
This manual has been produced in accordance with the procedures described in the
AUSVETPLAN Summary Document and in consultation with Australian national,
state and territory governments and the sheep and goat industries.
SGP is included on the OIE (World Organisation for Animal Health) list of notifiable
diseases as diseases of sheep and goats. This obliges OIE member countries that had
been free from these diseases to notify the OIE within 24 hours of confirming the
presence of SGP. OIE-listed diseases are diseases with the potential for international
spread, significant mortality or morbidity within the susceptible species and/or
potential for zoonotic spread to humans. 1
The strategies in this document for the diagnosis and management of an outbreak of
SGP are based on the recommendations in the OIE Terrestrial Animal Health Code 2 and
the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 3
In Australia, sheep pox and goat pox are included as Category 2 emergency animal
diseases in the Government and Livestock Industry Cost Sharing Deed in Respect of
Emergency Animal Disease Responses (EAD Response Agreement). 4
Text placed in square brackets [xxx] indicates that that aspect of the manual remains
contentious or is under development; such text is not part of the official manual. The
issues will be worked on by experts and relevant text included at a future date.
Detailed instructions for the field implementation of AUSVETPLAN are contained in
the disease strategies, operational procedures manuals, management manuals and wild
animal manual. Industry-specific information is given in the relevant enterprise
manuals. The full list of AUSVETPLAN manuals that may need to be accessed in an
emergency is shown below.
These criteria are described in more detail in Chapter 1.2 of the OIE Terrestrial Animal Health Code
(www.oie.int/index.php?id=169&L=0&htmfile=chapitre_1.1.2.htm).
2 www.oie.int/index.php?id=169&L=0&htmfile=chapitre_1.14.10.htm
3 www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.07.14_S_POX_G_POX.pdf
4 Information about the EAD Response Agreement can be found at
www.animalhealthaustralia.com.au/programs/emergency-animal-disease-preparedness/eadresponse-agreement/
1
Sheep pox and goat pox (Version 3.1)
3
4. Filename: SGP3.1-18FINAL(12Aug11).doc
In addition, Exotic Diseases of Animals: A Field Guide for Australian Veterinarians by
WA Geering, AJ Forman and MJ Nunn, Australian Government Publishing Service,
Canberra, 1995 (to be updated) is a source for some of the information about the
aetiology, diagnosis and epidemiology of the disease.
AUSVETPLAN manuals 5
Disease strategies
Individual strategies for each of 30
diseases
Bee diseases and pests
Response policy briefs (for diseases not
covered by individual manuals)
Operational procedures manuals
Decontamination
Destruction of animals
Disposal
Public relations
Valuation and compensation
Livestock management and welfare
Wild animal manual
Wild animal response strategy
Summary document
Enterprise manuals
Artificial breeding centres
Dairy processing
Feedlots
Meat processing
Poultry industry
Saleyards and transport
Zoos
Management manuals
Control centres management
(Parts 1 and 2)
Animal Emergency Management
Information System
Laboratory preparedness
The complete series of AUSVETPLAN documents is available on the internet at:
www.animalhealthaustralia.com.au/programs/emergency-animal-diseasepreparedness/ausvetplan/
5
4
AUSVETPLAN Edition 3
5. Filename: SGP3.1-18FINAL(12Aug11).doc
Contents
Preface .....................................................................................................................................3
1 Nature of the disease ......................................................................................................7
1.1
Aetiology and pathogenicity .............................................................................7
1.2
Susceptible species..............................................................................................8
1.2.1
1.2.2
1.2.3
Goats and sheep ....................................................................................8
Cattle .......................................................................................................8
Humans ..................................................................................................8
1.3
World distribution and occurrence in Australia ............................................8
1.4
Diagnostic criteria ...............................................................................................8
1.4.1
1.4.2
1.4.3
1.4.4
1.4.5
1.5
Resistance and immunity ................................................................................11
1.5.1
1.5.2
1.5.3
1.6
Clinical signs ..........................................................................................8
Pathology................................................................................................9
Laboratory tests .....................................................................................9
Differential diagnosis .........................................................................11
Treatment of infected animals ...........................................................11
Innate and passive immunity ............................................................11
Active immunity .................................................................................11
Vaccination...........................................................................................11
Epidemiology ....................................................................................................12
1.6.1
1.6.2
1.6.3
1.6.4
Incubation period ................................................................................12
Persistence of agent.............................................................................12
Modes of transmission .......................................................................13
Factors influencing transmission ......................................................14
1.7
Manner and risk of introduction to Australia...............................................14
1.8
Social and economic effects .............................................................................14
1.9
Criteria for proof of freedom...........................................................................15
2 Principles of control and eradication.........................................................................16
2.1
Critical factors assessed in formulating response policy ............................16
2.2
Options for control or eradication based on the assessed critical
factors .................................................................................................................16
3 Policy and rationale ......................................................................................................18
3.1
Introduction .......................................................................................................18
3.2
Control and eradication policy .......................................................................19
3.2.1
Stamping out........................................................................................19
Sheep pox and goat pox (Version 3.1)
5
6. Filename: SGP3.1-18FINAL(12Aug11).doc
3.2.2
3.2.3
3.2.4
3.2.5
3.2.6
3.2.7
3.2.8
3.2.9
3.2.10
3.2.11
3.2.12
Quarantine and movement controls ................................................ 19
Tracing and surveillance ................................................................... 20
Zoning and compartmentalisation ................................................... 20
Vaccination .......................................................................................... 21
Treatment of infected animals .......................................................... 21
Treatment of animal products .......................................................... 21
Disposal of animals and animal products ....................................... 22
Decontamination ................................................................................ 22
Wild animal and vector control ........................................................ 22
Public awareness and media ............................................................. 23
Public health implications ................................................................. 23
3.3
Other policies .................................................................................................... 23
3.4
Funding and compensation ............................................................................ 24
4 Recommended quarantine and movement controls .............................................. 25
4.1
Guidelines for classifying declared areas ..................................................... 25
4.1.1
4.1.2
4.2
Movement controls for SGP ............................................................................ 27
4.2.1
4.2.2
4.3
Declared premises .............................................................................. 25
Declared areas ..................................................................................... 26
Declared premises .............................................................................. 27
Declared areas ..................................................................................... 29
Criteria for issuing permits ............................................................................. 30
Appendix 1
Procedures for surveillance and proof of freedom............................ 31
Appendix 2
Key features of sheep pox and goat pox ............................................. 33
Glossary ............................................................................................................................... 34
Abbreviations...................................................................................................................... 41
References ............................................................................................................................ 42
Tables
Table 1.1 Laboratory tests currently available at CSIRO-AAHL for the
diagnosis of SGP ............................................................................................... 10
Table 4.1 Movement controls for declared premises ................................................... 27
Table 4.2 Movement controls for declared areas .......................................................... 29
Table A1 Summary of surveillance program for SGP .................................................. 32
6
AUSVETPLAN Edition 3
7. Filename: SGP3.1-18FINAL(12Aug11).doc
1 Nature of the disease
Sheep pox and goat pox (SGP) are highly contagious diseases of sheep and goats
characterised by papules and pustules (rarely vesicles) on exposed body surfaces,
and by fever, lacrimation, salivation and nasal discharge. Typical pox lesions
appear on the skin and on the respiratory and gastrointestinal mucosa. There is
high mortality in susceptible populations.
Currently, Australia is free from SGP. However, it is likely that any SGP virus that
enters Australia would be infective for both sheep and goats. An uncontrolled
outbreak of SGP in Australia would cause serious stock losses in the sheep and
goat industries, and an epidemic would have the potential to cause continuing
economic loss.
1.1
Aetiology and pathogenicity
The sheep pox, goat pox and lumpy skin disease viruses belong to the genus
Capripoxvirus of the family Poxviridae. Genome sequencing has shown that the
Capripoxvirus genus can be delineated into three distinct host ‘clusters’ — lumpy
skin disease virus (LSDV), sheep pox virus (SPV) and goat pox virus (GPV) —
despite the three sharing 97% nucleotide identity (Tulman et al 2002, Hosamani et
al 2004). The geographic distribution of lumpy skin disease (LSD) differs from that
of SGP.
The members of the genus Capripoxvirus are morphologically and serologically
indistinguishable from each other. However, as all strains of Capripoxvirus of ovine,
caprine or bovine origin examined so far share a major neutralising site, animals
that have recovered from infection with one strain are resistant to infection with
any other strain (Capstick 1961).
Field observations, such as Sheikh-Ali et al (2004) and Abu-Elzein et al (2003),
support the long-held view that SPV and GPV are generally host specific, but
numerous strains differ in host predilection and virulence. Instances of infection
with the same strain in mixed sheep and goat flocks simultaneously have been
recorded, although the strain will usually be more virulent in one of the two
species (Abu-Elzein et al 2003).
No seroconversion has been demonstrated from infected sheep or goats to incontact cattle, or from infected cattle to in-contact sheep or goats, although a
Kenyan LSD outbreak may have been derived from natural infections of cattle with
the endemic SPV (Davies 1991c). It appears that genes necessary for infection of
bovine hosts are effectively absent from SPV and GPV genomes (Tulman et al
2002).
Sheep pox and goat pox (Version 3.1)
7
8. Filename: SGP3.1-18FINAL(12Aug11).doc
1.2
Susceptible species
1.2.1
Goats and sheep
Merino and European breeds of sheep are more susceptible to sheep pox than
other breeds. Goat breeds also vary in susceptibility to goat pox, with breeds exotic
to the source area more severely affected (OIE 2004).
1.2.2
Cattle
The potential role of cattle in the epidemiology of these diseases under Australian
conditions would be determined during an outbreak by field observations.
Experience overseas is that cattle are unlikely to be significant in the course of an
SGP outbreak.
1.2.3
Humans
Humans are generally regarded as being nonsusceptible to SGP. In isolated
incidents, mild lesions of small red papules followed by vesicles on the hands and
arms have been reported in humans working with capripoxviruses in Sweden (von
Bakos and Brag 1957) and India (Sawhney et al 1972). No generalised infection
occurred.
1.3
World distribution and occurrence in Australia
SGP occurs in Africa, mainly north of the equator; the Middle East; Central and
Southeast Asia, including southern Russia and western China; and the Indian
subcontinent as far east as Myanmar (Burma). The geographical distribution of
sheep pox has been relatively stable.
For the latest information on the distribution of SGP, refer to the website of the OIE
World Animal Health Information Database. 6
SGP has never been recorded in Australia.
1.4
Diagnostic criteria
SGP should be considered when an acute disease with fever is accompanied by
pox-like skin lesions, and when there is a high mortality rate in sheep or goats.
However, some strains of low virulence may produce only mild clinical signs
(Davies 1976).
1.4.1
Clinical signs
Because sheep and goats in Australia are naive to capripoxviruses, the acute form
of SGP would be expected. This prediction is based on field reports of high
mortality in unprotected imported breeds of sheep and goats or indigenous breeds
that have not had regular exposure to local capripoxvirus strains (OIE 2004).
6
8
www.oie.int/wahid-prod/public.php?page=home
AUSVETPLAN Edition 3
9. Filename: SGP3.1-18FINAL(12Aug11).doc
A sudden onset of fever develops, which peaks at 40–42°C, with discharges from
the nose and eyes and excessive salivation. The animal loses its appetite and is
reluctant to move. Pox lesions erupt in 1–2 days and extend over all the skin, but
are most obvious where wool or hair is shortest, such as on the face, ears, axillae,
groin and perineum and under the tail. Lesions may be seen on the mucous
membranes of the mouth, nostrils and vulva. Acute respiratory distress occurs if
lung lesions are present.
The lesions follow the classical pox cycle, over about 2 weeks, of skin erythema
(redness), papule (0.5–1.5 cm diameter), vesicle (rare), pustule with exudation,
encrustation and scab formation. Exudate from ruptured pustules can cause the
fleece to matt. Healing of skin lesions is slow, taking 5–6 weeks. Deaths may occur
at any stage of the disease, with peak mortality occurring about 2 weeks after the
appearance of lesions. Mortality may reach 50% in adults and approach 100% in
young animals.
A peracute form of SGP is also seen in initial outbreaks in an area. This form is
characterised by fever, generalised haemorrhages, widespread cutaneous
ulceration and death.
A nodular form of SGP, called stonepox, can occur. Stonepox resembles LSD (of
cattle), with skin lesions 0.5–3 cm in diameter; these are hyperaemic (engorged
with blood), thickened and raised above the surrounding skin.
1.4.2
Pathology
Gross lesions
At postmortem examination, in addition to skin lesions, haemorrhagic ulcerations
may be found in the linings of the trachea and gastrointestinal tract. Lung lesions
consisting of small, pale grey nodules may be found.
Microscopic lesions (histopathology)
Histologically, pox lesions have extensive inflammatory, necrotic and proliferative
changes. The presence of Borrel cells or ‘cellules claveleuses’ (epithelioid cells that
infiltrate the lesions), and intracytoplasmic inclusion bodies similar to the
inclusions found with all poxviruses, are characteristic of SGP. Electron
microscopy reveals virus particles indistinguishable from the orthopoxviruses, and
these can be readily differentiated from the virus particles of contagious pustular
dermatitis.
1.4.3
Laboratory tests
Specimens required
Histopathology and virus detection are the essential laboratory tests. Virus
detection will be possible within the first week of development of clinical signs,
before the development of neutralising antibodies. Fresh tissue samples for
electron microscopy, virus isolation and viral antigen detection should be taken,
including whole blood in EDTA (to detect viraemia), skin lesion biopsies, and
scrapings from skin lesions and lesions in the respiratory and gastrointestinal
tracts during postmortem.
Sheep pox and goat pox (Version 3.1)
9
10. Filename: SGP3.1-18FINAL(12Aug11).doc
Transport of specimens
Specimens should initially be sent to the state or territory diagnostic laboratory.
From there, they will be forwarded to the CSIRO Australian Animal Health
Laboratory (CSIRO-AAHL), Geelong, for emergency disease testing, after the
necessary clearance has been obtained from the chief veterinary officer (CVO) of
the state or territory of the disease outbreak and after the CVO of Victoria has been
informed about the transport of the specimens to Geelong.
Unpreserved specimens and those preserved in glycerol–phosphate buffer should
be chilled and forwarded with water ice or frozen gel packs. For further
information, see the Laboratory Preparedness Manual.
Laboratory diagnosis
AAHL tests
A rapid, tentative diagnosis of SGP can be made by electron microscopy and
histopathology of tissue samples (see Section 1.4.2). Confirmation of the diagnosis
is obtained by specifically identifying the virus in tissues from early lesions or in
tissue culture using virus-specific tests, as well as by detecting viral DNA
(deoxyribonucleic acid) in tissue samples by TaqMan® or conventional polymerase
chain reaction (PCR). The diagnostic tests currently available at AAHL are shown
in Table 1.1; however, AAHL cannot prepare positive controls for virus isolation in
cell culture.
Table 1.1
Laboratory tests currently available at CSIRO-AAHL for the diagnosis of SGP
Test
Specimen
required
Test detects
Time taken to
obtain result
Electron microscopy
(negative contrast)
Tissue samples
Virus particles
1–2 hours
Real-time (Taqman®) PCR
Tissue samples
Viral DNA
1 day
Histopathology
Formalin-fixed
tissue
Characteristic pox
lesions
2 days
Conventional PCR and gene
sequencing
Tissue samples
Viral DNA
2 days
Virus isolation in cell culture
Tissue samples
Virus
4–14 days
Source: CSIRO–AAHL, 2006
Other tests
There is no good serological test for detecting SGP. Indirect immunofluorescence,
serum neutralisation and immunodiffusion tests have been used for detecting
antibody in sera; however, each of these tests has drawbacks.
Indirect immunofluorescence using immune sheep or goat sera is difficult to
interpret and is subject to nonspecific reactions (OIE 2004).
Serum neutralisation is the test of choice for serosurveillance, but has low
sensitivity due to the predominantly cell-mediated nature of immunity to
capripoxvirus. Thus, a negative result, particularly after vaccination, does not
indicate that the animal is not infected or protected (OIE 2004). The test is currently
unavailable in Australia.
10
AUSVETPLAN Edition 3
11. Filename: SGP3.1-18FINAL(12Aug11).doc
An enzyme-linked immunosorbent assay (ELISA) based on a specific
capripoxvirus antigen (P32) has been developed (OIE 2004). The test is unavailable
in Australia and is not currently used elsewhere.
1.4.4
Differential diagnosis
The following diseases should be considered in a differential diagnosis of SGP:
•
contagious pustular dermatitis (scabby mouth);
•
bluetongue;
•
mycotic dermatitis;
•
ectoparasites; and
•
photosensitisation.
1.4.5
Treatment of infected animals
No treatment is available for infected animals.
1.5
Resistance and immunity
Susceptible sheep and goats of all ages can be infected with SPV and GPV and
develop serious clinical disease. The introduction of SGP into a totally susceptible
population (in a country previously free from the disease) would probably result in
high mortalities and rapid spread of the disease (OIE 2004).
1.5.1
Innate and passive immunity
Different breeds of sheep and goats show varying degrees of natural resistance to
infection with SPV and GPV. Merino and European sheep breeds present in
Australia are very susceptible to sheep pox.
Maternal immunity provides protection from SGP for up to 3 months (Kitching
1986).
1.5.2
Active immunity
Animals that have recovered from capripoxvirus infection do not remain carriers
of the virus and have lifelong immunity.
1.5.3
Vaccination
Cell-cultured attenuated (‘live’) and inactivated vaccines have been used to
prevent SGP. Inactivated vaccines do not provide long-term protection, due at least
in part to their failure to induce a cell-mediated immune response, which is the
predominant protective response to poxvirus infection (OIE 2004).
Attenuated vaccines have been shown to induce relatively extended protection,
lasting from 12 months to lifetime (OIE 2004). Instances of live vaccine failure
when GPV strains have been used in sheep have prompted a recommendation for
the use of homologous vaccines (Agrawal and Soman 1997). However, a vaccine
made from a sheep and goat pox virus, which affected both sheep and goats in
Kenya, effectively immunised sheep, goats and cattle against infection with a
Sheep pox and goat pox (Version 3.1)
11
12. Filename: SGP3.1-18FINAL(12Aug11).doc
capripoxvirus. This vaccine was found to be stable and safe, and did not transmit
horizontally or vertically (Kitching et al 1986, Davies 1991b).
Immunised animals may not seroconvert to the vaccine.
Recipient species may react differently to attenuated vaccines. Vaccination of
susceptible saanen goats from a disease-free area with a live GPV vaccine resulted
in clinical goat pox with 100% morbidity and 41% mortality (Abo-Shehada 1990).
1.6
Epidemiology
1.6.1
Incubation period
The incubation period for SGP is usually 12 days but may vary from 4 to 14 days.
The OIE Terrestrial Animal Health Code gives a maximum incubation period, for
regulatory purposes, of 21 days.
1.6.2
Persistence of agent
General properties
Capripoxviruses are large, lipid-containing viruses that are susceptible to a range
of disinfectants, including detergents. They are susceptible to lipid solvents and
acids. Therefore, acids combined with detergents are the disinfectants of choice,
particularly for areas where organic matter is prevalent. Hypochlorites and
aldehydes are useful for disinfecting clean surfaces, and citric acid, alcohols and
iodophors are suitable for personal disinfection. The viruses are inactivated after
heating for 1 hour at 55°C.
Environment
Capripoxviruses are very stable in the environment and can remain viable for long
periods, on or off the animal host. They are susceptible to sunlight, but may persist
for up to 6 months in a cool, dark environment, such as in shaded animal pens
(Davies 1981).
Live animals
The SGP viruses may remain viable for at least 3 months after recovery in the
exudate from skin lesions that has accumulated in wool and hair (Davies 1981). No
carrier state has been demonstrated in recovered animals.
Equipment and personnel
Virus persists for at least 3 months in the wool, hair and scabs of infected animals,
and up to 6 months in the environment, including on fomites such as clothing and
equipment.
12
AUSVETPLAN Edition 3
13. Filename: SGP3.1-18FINAL(12Aug11).doc
1.6.3
Modes of transmission
Live animals
Most transmission is by direct contact via the respiratory system through shortdistance aerosol transmission from nasal secretions and saliva when sheep and
goats are congregated. However, transmission on fomites and mechanical
transmission by insects over short distances also occur (Kitching and Taylor 1985).
Affected sheep and goats shed the virus at every stage of the disease. Virus is
present in secretions and excretions of infected animals, including milk, and in
scabs from skin lesions, but these are not considered to be important sources of
transmission during an outbreak (Kitching and Taylor 1985).
Movement of infected animals is the main means by which SGP is spread to new
premises or new areas.
Host/species susceptibility should be determined as soon as SGP is detected in
Australia.
Animal products and byproducts
The SGP viruses are persistent and remain viable for at least 3 months in dry scabs
on the fleece, skins and hair from infected animals.
There is no evidence of virus persisting in the meat of infected animals, but it may
be isolated from the milk during the early stages of the fever (Davies 1991a,
Williams 2003).
Equipment and personnel
These viruses are readily transported on fomites, including clothing and
equipment.
Vectors
Insects may act as mechanical vectors of SPV and GPV over short distances. The
stable fly (Stomoxys calcitrans) can transmit the viruses to a susceptible goat
24 hours after it is itself contaminated (Kitching and Mellor 1986). Musca species
flies have also been implicated in mechanically transmitting the virus after feeding
on exudate from lesions (Kitching and Mellor 1986). There is no evidence of the
virus persisting longer than 4 days in insects.
Semen and embryos
Capripoxvirus is listed by Hare (1985) as one that is known to be excreted in semen
and could be transmitted by semen. No information is available on the
transmission of the virus in embryos. It should be assumed that the virus would be
found in semen and embryos during the viraemic period. The closely related LSDV
of cattle was reported by Weiss (Coetzer 2004) as being shed in the semen of
clinically affected bulls for up to 22 days and for at least 12 days in subclinically
affected bulls. The extremely resistant nature of the virus to the environment
would make venereal transmission very likely (NRC 1993).
Sheep pox and goat pox (Version 3.1)
13
14. Filename: SGP3.1-18FINAL(12Aug11).doc
1.6.4
Factors influencing transmission
SPV and GPV are not highly infectious, and intimate contact assists transmission.
This can occur during night herding or stabling in endemic areas (Davies 1981).
The movement of infected animals is the main means of spread over a large area.
In endemic areas, spread occurs mainly in summer.
1.7
Manner and risk of introduction to Australia
Movement of infected animals is the main means by which SGP is spread to new
premises or new areas. There is, however, little possibility of these diseases
entering Australia by this way, as imports of live sheep, cattle or goats, or their
semen or embryos, are not permitted from countries in which SGP or LSD is
endemic.
There is considerable risk of introduction of sheep pox to Australia on fomites
(such as in sheep vessels returning from the Middle East), and on clothing,
equipment and unprocessed wool products brought in by people from endemic
areas.
Transmission by biting insects seems to be mechanical rather than biological, so
insects on planes are probably an insignificant risk.
1.8
Social and economic effects
An uncontrolled outbreak of SGP would cause serious stock losses in the goat and
sheep industries. The resulting financial losses would have a serious effect on the
local economy in the area of the outbreak. Modelling of outbreaks of sheep pox of
different levels of severity have indicated that a severe outbreak in regions such as
northern Victoria and northern New South Wales might involve up to 50 infected
premises, and that more than 50 000 sheep and goats might have to be slaughtered
to achieve eradication (Garner and Lack 1995). This would involve huge disruption
to the industries, irrespective of the trade consequences.
If SGP became endemic, continuing economic loss would occur as a result of loss of
animals and the cost of preventative vaccination. Permanent loss of some export
markets would also be expected, together with associated downturn in the rural
economy and possibly increased rural unemployment. In the worst-case scenario,
Australia’s major wool, goat fibre and skin markets would be lost; however, this
loss could be alleviated if zoning were accepted. It would therefore be necessary to
act immediately to control and then eradicate SGP, and to quickly establish
Australia’s freedom from the disease so that the export trade in animal products
could be re-established.
Movement restrictions within the restricted area and control area (see Section 4)
would cause loss of market opportunities and associated financial losses to
nonaffected properties in the area, as well as short-term losses to support
industries, such as stock transport. Some industries not directly affected by SGP,
such as the cattle industry, may also be subject to movement restrictions.
The use of a stamping-out policy may not lead to the loss of significantly more
stock on infected premises than would be expected if the disease were not
14
AUSVETPLAN Edition 3
15. Filename: SGP3.1-18FINAL(12Aug11).doc
controlled. Prevention of restocking until after the prescribed period has elapsed
would impose serious problems on the cash flow of the infected premises and
dangerous contact premises involved.
If the outbreak occurred late in the vector season, eradication would be helped if
the cold weather killed the vectors, and the infected animals were destroyed and
disposed of quickly.
1.9
Criteria for proof of freedom
If a stamping-out policy were practised, Australia would be considered free from
SGP 6 months after the destruction of the last affected animal. To demonstrate to
Australia’s trading partners that the disease has been successfully contained and
eradicated, Australia must embark on a disease surveillance program during those
6 months.
As it is possible that the diseases may appear as subclinical or inapparent
infections, appropriate laboratory testing will be necessary to survey for the
presence of disease, as described in Appendix 1. Physical examinations of flocks
and herds will help provide proof of freedom.
Sheep pox and goat pox (Version 3.1)
15
16. Filename: SGP3.1-18FINAL(12Aug11).doc
2 Principles of control and eradication
2.1
Critical factors assessed in formulating response policy
Features of the disease:
•
Sheep pox and goat pox (SGP) are highly contagious diseases, often with high
mortality, so the disease should become apparent soon after introduction to a
closely settled area.
•
Acute cases (the most common type in naive populations) should be readily
diagnosed clinically as sheep pox and goat pox.
•
A rapid confirmatory diagnosis can be made.
•
Recovered animals are solidly immune.
•
There is no carrier state.
•
The virus is stable in the environment, especially in cool, shaded areas; fomites
are important in spread of the disease.
•
Under Australian conditions, mechanical transmission of the virus by biting
flies may be important.
Features of susceptible populations:
•
Australian sheep and goat populations are naive to the viruses and would not
be expected to produce mild or inapparent forms of the disease.
•
Movement of infected animals is the main means of spread over a large area.
•
The disease may establish in a feral goat population that is not easily
identified.
•
Market fluctuations due to public health perceptions or product withdrawals
would reduce the value of the industry.
•
Smallholder goat populations are not easily identified.
2.2
Options for control or eradication based on the
assessed critical factors
Managing the risk of SGP would be based on the identified critical factors and
would involve:
•
•
application of mandatory biosecurity programs;
•
16
registration of all commercial and small sheep and goat holdings — this is
essential to determine the location of small goat holdings;
the early determination of the extent of infection through the rapid
identification of infected and potentially infected premises using quickly
instituted serosurveillance and animal tracing, based on an epidemiological
assessment;
AUSVETPLAN Edition 3
17. Filename: SGP3.1-18FINAL(12Aug11).doc
•
the swift declaration and effective policing of control areas and the rapid
imposition of quarantine and movement controls on infected and potentially
infected premises, to prevent the movement of sheep, goats and fomites
carrying virus or potentially carrying virus;
•
minimising the exposure of susceptible animals by preventing direct and
indirect contact of at-risk sheep and goats with infected sheep and goats, and
potentially contaminated fomites;
•
elimination of infection from infected premises and/or infected populations
by the rapid destruction of sheep and goats, the sanitary disposal of carcases
and fomites, and decontamination;
•
identification of vectors of concern as quickly as possible and application of
appropriate treatments;
•
the implementation of zoning and/or compartmentalisation;
•
the possible use of vaccination with movement controls;
•
the gaining of smallholder support; and
•
feral goat population management.
The policy options for the control and eradication of SGP are:
•
recognition of endemic status (especially if the disease is found in the feral
goat population), using vaccination, and zoning/compartmentalisation;
•
modified stamping out if the disease is widespread when diagnosed or
spreads beyond available resources, using ring vaccination; and
•
stamping out.
The policy to be implemented is described in Section 3.
Sheep pox and goat pox (Version 3.1)
17
18. Filename: SGP3.1-18FINAL(12Aug11).doc
3 Policy and rationale
3.1
Introduction
Sheep pox and goat pox (SGP) are OIE-listed diseases that have the potential
for rapid spread. SGP has implications for sheep and goat production and
trade.
Sheep pox and goat pox are Category 2 diseases under the Emergency
Animal Disease Response Agreement. Category 2 diseases are those for
which costs will be shared 80% by government and 20% by industry.
The response policy is to eradicate SGP in the shortest possible period using
stamping out, supported by a combination of strategies, including:
sanitary disposal of destroyed animals and contaminated animal
products, to remove the source of infection;
quarantine and movement controls over animals, products and other
potentially contaminated items to minimise spread of infection;
decontamination of fomites (facilities, equipment and other items) to
minimise the spread of the virus from infected animals and premises;
tracing and surveillance to determine the source and extent of infection
and to provide proof of freedom from the disease;
zoning and/or compartmentalisation to define infected and disease-free
premises and areas; and
an awareness campaign to facilitate cooperation from the industry and
the community.
Ring vaccination may be utilised as part of a modified stamping-out policy
(for example, if feral goats are involved in the outbreak).
The chief veterinary officer (CVO) in the state or territory in which the outbreak
occurs is responsible for developing an Emergency Animal Disease (EAD)
Response Plan for the particular outbreak.
The Consultative Committee on Emergency Animal Diseases (CCEAD), convened
for the incident, assesses the response plan drawn up by the CVO for technical
soundness and consistency with AUSVETPLAN, and endorses or seeks
modifications to it. Overall operational management of the incident rests with the
CVO of the affected jurisdiction, with oversight by the CCEAD.
The National EAD Management Group (NMG), also convened for the specific
incident, decides on whether cost sharing will be invoked (following advice from
the CCEAD) and manages the national policy and resourcing needs.
For further details, refer to the Summary Document.
18
AUSVETPLAN Edition 3
19. Filename: SGP3.1-18FINAL(12Aug11).doc
CVOs will implement disease control measures as agreed in the EAD Response
Plan and in accordance with relevant legislation. They will make ongoing decisions
on follow-up disease control measures in consultation with the CCEAD and the
NMG, based on epidemiological information (see Section 1.6) about the
outbreak(s).
For information on the responsibilities of the state or territory disease control
headquarters and local disease control centres, see the Control Centres
Management Manual.
3.2
Control and eradication policy
The requirement for a quick return to international trade highlights the need for
rapid eradication by stamping out, the need to combine this policy with quarantine
of infected and suspect premises, and the need to quickly determine the source of
infection and the extent of spread so that proper and adequate control measures
can be applied.
Any animal disease eradication or control program must include close liaison and
information exchange with industry, the media and the public.
3.2.1
Stamping out
The policy for controlling SGP in Australia is to use stamping out. This will involve
the destruction of susceptible animals on infected premises (IPs) and dangerous
contact animals on dangerous contact premises (DCPs). Until further information
is available, sheep and goats will be considered to be the susceptible species.
If a DCP contains relatively few susceptible animals in addition to the dangerous
contacts, all animals will be destroyed. If, on the other hand, there is a large
number of stock on the premises, only the dangerous contact animals will be
destroyed, and the other animals will be quarantined and observed for 21 days for
signs of disease. Such a strategy will depend to a large extent on the degree of
separation able to be achieved between the groups of animals and the possibility of
mechanical transfer by insect vectors or by other means.
Although experience overseas is that cattle are unlikely to be significant in the
course of an SGP outbreak, any cattle in nose-to-nose contact with infected sheep
or goats may need to be included in the stamping-out program.
3.2.2
Quarantine and movement controls
As the main form of transmission is by direct contact with infected animals or
contaminated products and things, quarantine and movement controls will
prevent the rapid spread of disease. The IPs, DCPs and suspect premises (SPs) will
immediately be declared.
A restricted area (RA), which will contain all IPs and DCPs and as many SPs as
possible, will be determined following tracing and surveillance activities. The RA
should have its boundary at least 5 km from the IP, with at least two stock-proof
fences between the IP and the boundary. The size of the RA will be determined by
the presence of possible vectors and feral animals within the RA and will probably
be much larger than this.
Sheep pox and goat pox (Version 3.1)
19
20. Filename: SGP3.1-18FINAL(12Aug11).doc
A control area (CA) will be formed around the RA, with its boundary at least 5 km
from the RA boundary. To be realistic, this area should be as large as possible to
allow animals to be marketed and processed within the area. It would be
preferable to try to include a meat- and skin-processing establishment within the
area.
All movement of susceptible animals within the RA will be prohibited for an initial
period of at least 21 days so that the animals within the area can be observed by
direct physical examination and appropriate diagnostic tests. Animals on DCPs
and SPs will be examined daily for the first 2 weeks and then at weekly intervals.
Other properties in the RA will be examined weekly.
In the absence of any signs of disease during this 21-day period of observation,
animals from the DCPs and IPs may be sent for slaughter, under permit, at
approved abattoirs. They will not be held in the lairage any longer than the
minimum time required for meat hygiene purposes. Movement controls within the
CA may be less restrictive, but live animal movements out of the CA will be
prohibited for the 21-day observation period.
See Section 4 for further details on declared areas and on quarantine and
movement controls.
3.2.3
Tracing and surveillance
Tracing of suspect animals, products, people and things must take in the period
from at least 21 days before the first clinical signs were observed on the initial IP to
the time the premises was placed under quarantine. Tracing must be thorough and
detailed, because the SGP viruses may persist on inanimate materials and survive
outside the host for some time.
Surveillance will include an epidemiological study of the possible vectors that may
play a role in transmission of the virus and the ecological factors likely to influence
the distribution and survival of the vectors. This information will help in
determining the size of the RA by taking into consideration the possible spread of
virus by insect vectors.
Susceptible animals on DCPs and SPs will be physically examined on a daily basis
for the first 14 days and weekly thereafter, as will all susceptible animals in the RA
(or a statistical sample if large numbers of susceptible animals are involved).
Sentinel animals may be introduced to the IPs and DCPs after stamping out and
decontamination have been completed. These animals will be examined weekly
and appropriately tested over a period of at least 6 weeks. Repopulation may occur
after this time if all findings are negative. The repopulated animals will also be
subjected to surveillance for at least a further 3 months.
See Appendix 1 for further details on surveillance.
3.2.4
Zoning and compartmentalisation
Should stamping out be successful, the area defined by the CA will represent an
infected zone for only a short period. This will eliminate the need for establishing
and proposing free zones, which would only be considered if the disease
established itself in a region without detection and was difficult to eradicate in the
20
AUSVETPLAN Edition 3
21. Filename: SGP3.1-18FINAL(12Aug11).doc
short term. If this should occur, discrete subpopulations of susceptible species
would need to be defined, risk assessments conducted and data collated to support
and provide assurances for long-term biosecurity management of the free zone.
3.2.5
Vaccination
If a disease outbreak outstrips the resources available to control it through
stamping out, a ring vaccination program will provide a buffer zone of immune
animals around the disease area until the outbreak can be brought under control. It
is unlikely that Australia will use vaccination except as a last resort — for example,
where domestic animals are in contact with infected feral goats, and quick
eradication in feral goats is not feasible.
See Section 1.5.3 for further details on vaccination, including the vaccines available
and methods of vaccination.
3.2.6
Treatment of infected animals
Infected or susceptible animals will not be treated.
3.2.7
Treatment of animal products
Animals that have been cleared after the period of observation may be sent to
slaughter and the meat released for human consumption.
Skins and fibre are high-risk products because the virus may remain viable on
them for some months. Skins and fibre from IPs and DCPs will be destroyed on the
premises. All wool, skins, and goat fibre that have left those premises within the
21-day period before the diagnosis will be traced and suitably treated or destroyed;
other wool, skins, and goat fibre may be moved under permit for processing
elsewhere. Bales of wool, for example, may be allowed to go to a processing plant
if shearing occurred before the introduction of disease and there was no contact
with susceptible animals. Skins of little commercial value will be destroyed on the
premises.
Milk from susceptible species will be destroyed on the premises or moved under
permit for processing elsewhere. Milk that has left the premises within the 21-day
period before the diagnosis of disease will be traced and, if found, suitably treated
by heat or chemicals or destroyed.
Crops and grains may be moved off IPs and DCPs, subject to decontamination
procedures if it is considered likely that the material is contaminated. The material
will not be used as bedding or fodder for susceptible animals.
Accumulated faeces, fibre and skin pieces around and under sheds where infected
and suspect animals have congregated will be decontaminated and disposed of on
the premises.
Semen and embryos will not be collected from animals that are subject to
restrictions. An informed judgment on stored product will be made when all
relevant information is available.
All persons leaving the quarantine area must undergo
decontamination, including a change of clothing and footwear.
Sheep pox and goat pox (Version 3.1)
appropriate
21
22. Filename: SGP3.1-18FINAL(12Aug11).doc
3.2.8
Disposal of animals and animal products
Animal product and byproduct disposal will follow the same principles as those
for carcase disposal (see the Disposal Manual). Disposal methods (such as burning
or burial) will prevent further spread of the disease through contact with
susceptible animals.
If there may be a delay between destruction and disposal, the carcases will be
sprayed with phenol, covered with straw (kept wet with phenol), and guarded
continuously to prevent interference from vermin or predators. Insects that are
potential vectors will be controlled.
The disposal method chosen must be suited to the location and product at that
particular time (see the Decontamination Manual and the Disposal Manual for
more information).
3.2.9
Decontamination
A detailed and thorough decontamination program is required because of the
persistence of the virus outside the host. Fomites play an important role in
transmission of SGP, and all fomites will be decontaminated or destroyed.
Decontamination will include pens and yards where infected or suspect animals
have been held, with special attention paid to shearing and fleece-handling areas
and to dairies. All potentially contaminated fleeces and woolpacks must be burned
or buried.
Vehicles and people leaving the premises will be decontaminated.
Further information is available in the Decontamination Manual and in Geering et
al (1995).
3.2.10 Wild animal and vector control
If the disease occurs in an area where there are feral goat populations, a goat
culling or control program, combined with surveillance, will be established to
determine whether the infection has entered the population. Control measures
must be such that wild animal populations are not induced to disperse out of the
RA. A range of options may be available, such as baiting, trapping and decoy
feeding.
If SGP escapes into the feral goat population, a buffer zone around the goat
population would be necessary to contain the disease. This buffer zone may be
formed by depopulating the area of goats and sheep, or by ring vaccination. See
the Wild Animal Response Strategy for more information on goat control.
Disposal of contaminated materials (including feedstuffs) and carcases will be
prompt to minimise exposure of susceptible feral species, wild predators and
vermin to SGP virus.
The epidemiological investigation team, which will include an entomologist, will
identify vectors that could play a role in the transmission of SGP and develop a
targeted approach to vector control to block the transmission cycle.
It is possible that several vectors may be present that may be able to mechanically
transmit the virus, and this may require a range of approaches to control. These
22
AUSVETPLAN Edition 3
23. Filename: SGP3.1-18FINAL(12Aug11).doc
might include the aerial and ground application of insecticides as ultra-lowvolume (ULV) fogs, and treatment of animals (within, say, 5 km of IPs) with either
a systemic insecticide such as ivermectin, or a topical insecticide that will repel
insects or reduce the population of target insects. Insect-proof housing for animals
might also be considered.
Surveillance for vectors both in the free and infected areas will be ongoing to
ensure that the disease is not being spread by this method.
3.2.11 Public awareness and media
A media campaign will emphasise the importance of inspecting sheep and goats
for pox lesions, and of reporting suspicious lesions and unusual deaths promptly.
The risks associated with raw wool and skins will be stressed.
Entry of the disease into highly susceptible sheep and goat populations is likely to
result in high morbidities and mortalities. Many animals will need to be
slaughtered if infection occurs in a number of herds or flocks, even if the disease is
mild or subclinical. Industry will be made aware of the control measures, and
regular liaison with industry will be undertaken. The media can play a role in
conveying information to the public to help maintain confidence in the product
and explain the need for the control measures.
3.2.12 Public health implications
There are no public health implications.
3.3
Other policies
Modified stamping out, using ring vaccination, would be the policy implemented
if the disease were widespread when diagnosed or had spread beyond the
resources available for stamping out.
It is unlikely that an outbreak of SGP would not be eradicated. However, if SGP
were not able to be contained through the above policies, recognition of endemic
status may be necessary (especially if the disease were found in the feral goat
population).
If SGP became established in Australia, the diseases in domestic animals would be
controlled by vaccination, with an appropriate vaccine, of all susceptible animals in
areas where the disease occurred. Vaccination of the entire susceptible population
against SGP should result in the field virus dying out, allowing widespread
vaccination to be discontinued after only a couple of years and replaced by ring
vaccination.
Zoning/compartmentalisation would be used to prevent movement of susceptible
animals and materials from the infected areas.
Sheep pox and goat pox (Version 3.1)
23
24. Filename: SGP3.1-18FINAL(12Aug11).doc
3.4
Funding and compensation
Sheep pox and goat pox are classified as Category 2 emergency animal diseases
under the EAD Response Agreement between the governments of Australia and
the livestock industries.
Category 2 diseases are emergency animal diseases that have the potential to cause
major national socioeconomic consequences through very serious international
trade losses, national market disruptions and very severe production losses in the
livestock industries that are involved. Category 2 also includes diseases that may
have slightly lower national socioeconomic consequences, but also have significant
public health or environmental consequences. For Category 2 diseases, the costs
will be shared 80% by governments and 20% by the relevant industries (refer to the
EAD Response Agreement for details). 7
Information on the cost-sharing arrangements can be found in the Summary
Document and in the Valuation and Compensation Manual.
See www.animalhealthaustralia.com.au/programs/emergency-animal-disease-preparedness/eadresponse-agreement/
7
24
AUSVETPLAN Edition 3
25. Filename: SGP3.1-18FINAL(12Aug11).doc
4 Recommended quarantine and
movement controls
4.1
Guidelines for classifying declared areas
A declared area is a part of a country with defined boundaries that is subject to
mandatory disease control measures (such as animal movement controls, animal
destruction, decontamination) under emergency animal disease legislation. Types
of declared areas include restricted area, control area, infected premises, dangerous
contact premises and suspect premises, but not all classifications are relevant to all
diseases.
4.1.1
Declared premises
Infected premises
A premises classified as an infected premises (IP) will be a defined area (which
may be all or part of a property) in which sheep pox and goat pox (SGP) or their
respective disease agents exist, or are believed to exist. An IP will be subject to
quarantine served by notice, and to eradication and control procedures.
Dangerous contact premises
Premises classified as dangerous contact premises (DCPs) will be those premises
that contain animals, animal products, waste or other items that have recently been
introduced from an IP (up to 21 days before the premises were declared infected)
and are likely to be infected or contaminated, or any of these items that may have
been in substantial contact with people, vehicles and equipment that have been
associated with an IP within 21 days of visiting the DCP.
Premises classified as DCPs will be:
•
all neighbouring properties on which susceptible animals have been sharing a
common fenceline with infected animals on an IP and where it is considered
necessary to impose disease control measures;
•
all properties to which susceptible animals have moved from an IP within
21 days before the first appearance of clinical signs on the IP and where it is
considered necessary to impose disease control measures; and
•
all other properties owned or managed in conjunction with an IP, due to
concerns with movement of people, equipment and vehicles within 21 days
before the first appearance of clinical signs on the IP.
DCPs will be subject to quarantine and to eradication or control measures.
Suspect premises
Premises classified as suspect premises (SPs) will be those other than DCPs that
contain animals that are showing clinical signs needing differential diagnosis.
Sheep pox and goat pox (Version 3.1)
25
26. Filename: SGP3.1-18FINAL(12Aug11).doc
SPs will be subject to quarantine and intensive surveillance.
‘Suspect premises’ is a temporary classification because the premises contains
animals that are suspected of having the disease. High priority should be given to
clarifying the status of the suspect animals so that the SP can be reclassified either
as an IP and appropriate quarantine and movement controls implemented, or as
free from disease, in which case no further disease control measures are required.
4.1.2
Declared areas
Restricted area
A restricted area (RA) will be a relatively small declared area (compared with a
control area — see below) around IPs that is subject to intense surveillance and
movement controls. Movement out of the area will generally be prohibited, while
movement into the area would only be by permit. Multiple RAs may exist within
one control area.
The RA can have an irregular perimeter, provided that the boundary is initially an
appropriate distance from the nearest IP, DCP or SP. The boundary distance will
vary with the size and nature of the potential source of disease agent, but will be at
least a 5-km radius around the IP, depending on the density of premises. In
addition, there should be at least two stock-proof barriers between the IP and the
boundary of the RA. Where stock-proof barriers do not exist, the RA should also
include an area substantially larger than the home range of any susceptible feral
species that may come into contact with the IPs or DCPs. The boundary could be
the perimeter fence of the IP if the IP is in an isolated location. The boundary in a
densely populated area will take into account the distribution of susceptible
animals; traffic patterns to markets, service areas and abattoirs; and areas that
constitute natural barriers to movement.
Control area
The control area (CA) will be a larger declared area around the RA(s) and, initially,
possibly as large as a state or territory, where restrictions will reduce the risk of
disease spreading from the RA(s). The boundary of the CA will be adjusted as
confidence about the extent of the outbreak increases; however, it must remain
consistent with the OIE Terrestrial Code chapters on zoning and
compartmentalisation (see Chapter 4.3 of the code) 8 and surveillance (see
Chapter 1.4 of the code). 9 In general, surveillance and movement controls will be
less intense than for the RA, and animals and products may be permitted to move
under permit from the area.
The declaration of a CA also helps to control the spread of the outbreak from
within the RA. The CA is a buffer zone between the RA and the rest of the
industry. The boundary does not have to be circular or parallel to that of the RA
but should be at least 5 km from the boundary of the RA, and there should be at
8
www.oie.int/index.php?id=169&L=0&htmfile=chapitre_1.4.3.htm
9
www.oie.int/index.php?id=169&L=0&htmfile=chapitre_1.1.4.htm
26
AUSVETPLAN Edition 3
27. Filename: SGP3.1-18FINAL(12Aug11).doc
least two stock-proof barriers between the two. In general, the movement of
possibly contaminated items and materials within the CA is allowed, but
movement out of the CA is prohibited without chief veterinary officer approval.
This type of control area allows reasonable commercial activities to continue.
4.2
Movement controls for SGP
4.2.1
Declared premises
Table 4.1 shows the movement controls that will apply to IPs, DCPs and SPs in the
event of an SGP incident.
Table 4.1
Movement controls for declared premises
Quarantine/movement
controls
Movement out of:
Infected and dangerous
contact premises
Suspect premises
– susceptible animals
Prohibited, except after
observation period of
21 days; may be allowed to
go to slaughter under
permit
As for IPs and DCPs
– nonsusceptible
animals
Allowed under permit,
subject to decontamination
Allowed under permit
– wool, fibre, skins, etc
Prohibited
Allowed under permit
for processing, subject to
decontamination
– milk products from
susceptible species
Allowed under permit for
processing using
appropriate milk tankers
As for IPs and DCPs
– semen and embryos
Allowed under permit
As for IPs and DCPs
– crops and grains
Allowed under permit,
subject to decontamination
Allowed
– people
Allowed under permit,
subject to decontamination
No restriction, but must
undergo
decontamination if they
have had contact with
suspect animals
– vehicles and
equipment
Allowed under permit,
subject to decontamination
No restriction, but must
undergo
decontamination if they
have had contact with
suspect animals
Movement in and out of:
Sheep pox and goat pox (Version 3.1)
27
29. Filename: SGP3.1-18FINAL(12Aug11).doc
4.2.2
Declared areas
Table 4.2 shows the movement controls that will apply to RAs and CAs (if
declared) in the event of an SGP incident.
Table 4.2
Movement controls for declared areas
Quarantine/ movement
controls
Movement out of:
Restricted area (if declared)
Control area (if
declared)
– susceptible animals
Prohibited, except after
observation period of 21 days;
may be allowed to go to
slaughter under permit
As for RA
– vehicles and
equipment
Allowed under permit, subject
to decontamination
Allowed
– wool, fibre, skins, etc
Allowed under permit, subject
to decontamination
Allowed under permit
– milk products from
susceptible species
Allowed under permit, subject
to decontamination
Allowed under permit
– semen and embryos
Allowed under permit
As for RA
– nonsusceptible
animals, people
Allowed under permit, subject
to decontamination
Allowed
– susceptible animals
Prohibited until end of 21-day
observation period
Permit required until
end of 21-day
observation period
– wool, fibre, skins, etc
Allowed under permit
As for RA
– milk products from
susceptible species
Allowed under permit
As for RA
Allowed under permit
As for RA
– susceptible animals
Allowed under permit
As for RA
Movement of
susceptible animals
along stock routes,
rights of way
Prohibited
As for RA
– skin dealers and
shearers
Prohibited
As for RA
Sales, shows, etc
Prohibited if susceptible
animals are involved
As for RA
Movement within of:
Movement through of:
– susceptible animals
Movement in of:
Risk enterprises:
Sheep pox and goat pox (Version 3.1)
29
30. Filename: SGP3.1-18FINAL(12Aug11).doc
4.3
Criteria for issuing permits
When conducting a risk assessment regarding the issuing of a permit, the officer
should take into account the following:
•
•
species of animal;
•
confidence in animal tracing and surveillance;
•
destination and use of the animals or products;
•
likelihood of contamination of the product or material (and ability to
decontaminate); and
•
30
status of the originating and destination premises;
security of transport.
AUSVETPLAN Edition 3
31. Filename: SGP3.1-18FINAL(12Aug11).doc
Appendix 1 Procedures for surveillance and
proof of freedom
Sheep pox and goat pox (SGP) must be notified at the first clinical signs of the
diseases. Farmers, veterinarians and meat workers must be alert and report
suspicion of disease.
According to the OIE Terrestrial Code, a country’s claim for freedom from SGP
cannot be made until it has been shown that the disease has not been present for at
least the past 6 months after the slaughter of the last affected animal (for countries
in which a stamping-out policy is practised with or without vaccination). All atrisk properties (see note 1) must therefore be kept under close surveillance for
6 months.
Detection of disease is to be from physical examination of flocks, as well as
through appropriate laboratory testing.
On infected premises (IPs), and on dangerous contact premises (DCPs) that have
been destocked, sentinel animals may be introduced after decontamination is
completed. These animals should undergo weekly physical inspection with
appropriate testing for 6 weeks, when restocking may occur (see note 3). The flock
should be inspected at 1-month intervals for 3 months. If no suspicion of disease is
detected by then (about 6 months after the completion of cleaning and
disinfection), the property may be released from quarantine.
On other properties in the restricted area (RA), physical inspection surveillance
visits (see note 2) should be made as soon as possible after the first IP is declared in
the RA and then 1, 2, 3 and 6 weeks later.
A final inspection may be needed 6 months after the last case.
Notes
(1)
Premises considered to be at risk are all premises within the RA with
susceptible animals, IPs, DCPs and other properties considered to have had
significant contact with an IP.
(2)
At physical inspection surveillance visits, every mob of susceptible animals
must be inspected and numbers accounted for. In extensive grazing areas,
where the degree of contact between groups of animals in a flock may be
low, care must be taken to ensure that all groups of animals are present and
healthy.
(3)
Animals dying within 12 months after repopulation of IPs must be autopsied
and appropriate samples taken for virus testing.
Sheep pox and goat pox (Version 3.1)
31
32. Filename: SGP3.1-18FINAL(12Aug11).doc
Table A1
Summary of surveillance program for SGP
IPs and DCPs
Restricted area (other than IPs and
DCPs)
Day 0
Decontamination completed
Week 1
Introduce sentinel animals
Clinical exam
Week 2
Clinical exam
Clinical exam
Week 3
Clinical exam
Clinical exam
Week 4
Clinical exam
Week 5
Clinical exam
Week 6
Clinical exam
Week 7
Clinical exam + restock
Week 8
Flock inspection
Month 3
Flock inspection
Month 5
Flock inspection
Month 6
32
Flock inspection
Month 4
Clinical exam + release from quarantine
Flock inspection + release from
quarantine
AUSVETPLAN Edition 3
33. Filename: SGP3.1-18FINAL(12Aug11).doc
Appendix 2 Key features of sheep pox and
goat pox
Disease and cause
Sheep pox and goat pox are highly contagious skin diseases of sheep and goats,
characterised by papules and pustules (and rarely vesicles) on exposed body
surfaces, often with high mortality. The diseases are caused by viruses of the
Capripoxvirus genus of the family Poxviridae.
Species affected
As the names imply, these diseases affect sheep and goats. The viruses are usually
host specific for either sheep or goats, but some strains affect both species. Merino
and European breeds of sheep are most susceptible. Humans are considered
nonsusceptible.
Distribution
Sheep pox and goat pox occur in Africa (mainly north of the equator), the Middle
East, Central and Southeast Asia, and the Indian subcontinent as far east as
Myanmar (Burma). Neither of these diseases has ever been recorded in Australia.
Key signs
Both diseases are characterised by sudden onset of fever with nasal and eye
discharges and excessive salivation. The diseases may be mild in indigenous
breeds of sheep and goats from endemic areas, but are often fatal in newly
introduced animals. In 1–2 days, classical pox lesions develop over all of the skin,
but are most obvious where wool or hair is short. Lesions may occur on the
mucous membranes of the mouth, nostrils and vulva. Acute respiratory distress
occurs if lesions develop in the lungs. Fluid from the lesions causes matting of the
fleece. Lesions also develop in the gastrointestinal tract, trachea and lungs. Deaths
may result at any stage, but peak mortality usually occurs about 2 weeks after the
development of lesions. Mortality may reach 50% in adults and approach 100% in
young animals.
Spread
Both diseases are highly infectious. The incubation period is usually 12 days, but
ranges from 2 to 14 days. Virus is present in all secretions and excretions of
infected animals at every stage of the diseases, including milk and scabs from skin
lesions. Transmission is mainly via the respiratory system but may be through
abraded skin. Movement of infected animals is the main way disease is spread to a
new premises or area. Insects can act as mechanical vectors of the virus over short
distances. Recovered animals do not remain carriers of the virus and have lifelong
immunity.
Persistence of the virus
The virus is very resistant to inactivation both on and off the host. It can persist for
up to 3 months in wool and hair from infected animals, for up to 6 months in the
environment, and for many years in dried scabs at ambient temperatures. There is
no evidence that the virus persists in meat from infected animals.
Sheep pox and goat pox (Version 3.1)
33
34. Filename: SGP3.1-18FINAL(12Aug11).doc
Glossary
Animal byproducts
Animal Health
Committee
A committee comprising the CVOs of Australia and New
Zealand, Australian state and territory CVOs, Animal
Health Australia, and a CSIRO representative. The
committee provides advice to PIMC on animal health
matters, focusing on technical issues and regulatory policy
(formerly called the Veterinary Committee).
See also Primary Industries Ministerial Council (PIMC)
Animal products
Meat, meat products and other products of animal origin
(eg eggs, milk) for human consumption or for use in
animal feedstuff.
Australian Chief
Veterinary Officer
The nominated senior veterinarian in the Australian
Government Department of Agriculture, Fisheries and
Forestry who manages international animal health
commitments and the Australian Government’s response
to an animal disease outbreak.
See also Chief veterinary officer
AUSVETPLAN
Australian Veterinary Emergency Plan. A series of technical
response plans that describe the proposed Australian
approach to an emergency animal disease incident. The
documents provide guidance based on sound analysis,
linking policy, strategies, implementation, coordination
and emergency-management plans.
Chief veterinary officer
(CVO)
The senior veterinarian of the animal health authority in
each jurisdiction (national, state or territory) who has
responsibility for animal disease control in that
jurisdiction.
See also Australian Chief Veterinary Officer
Compensation
The sum of money paid by government to an owner for
stock that are destroyed and property that is compulsorily
destroyed because of an emergency animal disease.
See also Cost-sharing arrangements, Emergency Animal
Disease Response Agreement
Consultative Committee
on Emergency Animal
Diseases (CCEAD)
34
Products of animal origin that are not for consumption but
are destined for industrial use (eg hides and skins, fur,
wool, hair, feathers, hooves, bones, fertiliser).
A committee of state and territory CVOs, representatives
of CSIRO Livestock Industries and the relevant industries,
and chaired by the Australian CVO. The CCEAD convenes
and consults when there is an animal disease emergency
due to the introduction of an emergency animal disease of
livestock, or other serious epizootic of Australian origin.
AUSVETPLAN Edition 3
35. Filename: SGP3.1-18FINAL(12Aug11).doc
Control area
A declared area in which the conditions applying are of
lesser intensity than those in a restricted area (the limits of
a control area and the conditions applying to it can be
varied during an outbreak according to need).
See Section 4 for further details
Cost-sharing
arrangements
Arrangements agreed between governments (national,
state and territory) and livestock industries for sharing the
costs of emergency animal disease responses.
See also Compensation, Emergency Animal Disease
Response Agreement
Dangerous contact
animal
A susceptible animal that has been designated as being
exposed to other infected animals or potentially infectious
products following tracing and epidemiological
investigation.
Dangerous contact
premises
A premises that may or may not contain a susceptible
animal(s), including those not showing clinical signs, but,
following a risk assessment, are considered highly likely to
contain an infected animal(s) or contaminated animal
products, wastes or things, which present an unacceptable
risk to the response if not addressed.
See Section 4 for further details
Declared area
A defined tract of land that is subjected to disease control
restrictions under emergency animal disease legislation.
Types of declared areas include restricted area, control area,
infected premises, dangerous contact premises and suspect
premises.
See Section 4 for further details
Decontamination
Includes all stages of cleaning and disinfection.
Depopulation
The removal of a host population from a particular area to
control or prevent the spread of disease.
Destroy (animals)
To kill animals humanely.
Disease agent
A general term for a transmissible organism or other factor
that causes an infectious disease.
Disease Watch Hotline
24-hour freecall service for reporting suspected incidences
of exotic diseases — 1800 675 888
Disinfectant
A chemical used to destroy disease agents outside a living
animal.
Disinfection
The application, after thorough cleansing, of procedures
intended to destroy the infectious or parasitic agents of
animal diseases, including zoonoses; applies to premises,
vehicles and different objects that may have been directly
or indirectly contaminated.
Sheep pox and goat pox (Version 3.1)
35
36. Filename: SGP3.1-18FINAL(12Aug11).doc
Disposal
Emergency animal
disease
A disease that is (a) exotic to Australia or (b) a variant of an
endemic disease or (c) a serious infectious disease of
unknown or uncertain cause or (d) a severe outbreak of a
known endemic disease, and that is considered to be of
national significance with serious social or trade
implications.
See also Endemic animal disease, Exotic animal disease
Emergency Animal
Disease Response
Agreement
Agreement between the Australian Government and state
or territory governments and livestock industries on the
management of emergency animal disease responses.
Provisions include funding mechanisms, the use of
appropriately trained personnel and existing standards
such as AUSVETPLAN.
See also Compensation, Cost-sharing arrangements
Endemic animal disease
A disease affecting animals (which may include humans)
that is known to occur in Australia.
See also Emergency animal disease, Exotic animal disease
Enterprise
See Risk enterprise
Enzyme-linked
immunosorbent assay
(ELISA)
A serological test designed to detect and measure the
presence of antibody or antigen in a sample. The test uses
an enzyme reaction with a substrate to produce a colour
change when antigen–antibody binding occurs.
Epidemiological
investigation
An investigation to identify and qualify the risk factors
associated with the disease.
See also Veterinary investigation
Erythema
Superficial redness of the skin due to dilation of the
capillaries.
Exotic animal disease
A disease affecting animals (which may include humans)
that does not normally occur in Australia.
See also Emergency animal disease, Endemic animal
disease
Exotic fauna/feral
animals
See Wild animals
Fomites
Inanimate objects (eg boots, clothing, equipment,
instruments, vehicles, crates, packaging) that can carry an
infectious disease agent and may spread the disease
through mechanical transmission.
Immunodiffusion test
36
Sanitary removal of animal carcases, animal products,
materials and wastes by burial, burning or some other
process so as to prevent the spread of disease.
A serological test to identify antigens or antibodies by
precipitation of antibody–antigen complexes after
diffusion through agar gel.
AUSVETPLAN Edition 3
37. Filename: SGP3.1-18FINAL(12Aug11).doc
In-contact animals
Animals that have had close contact with infected animals,
such as noninfected animals in the same group as infected
animals.
Incubation period
The period that elapses between the introduction of the
pathogen into the animal and the first clinical signs of the
disease.
Indirect
immunofluorescence
A technique in which the presence of antigen or antibody
in a sample can be detected by binding of a specific
antibody bound to a fluorescent marker molecule, which is
visible under a fluorescence microscope.
Infected premises
A defined area (which may be all or part of a property) in
which an emergency disease meeting the case definition
exists or is believed to exist, or in which the causative
agent of that emergency disease exists or is believed to
exist.
See Section 4 for further details
Lairage
Shed or outdoor enclosure for the temporary housing of
animals; for example, on the way to market, or when they
are being transported for export.
Local disease control
centre (LDCC)
An emergency operations centre responsible for the
command and control of field operations in a defined area.
Movement control
Restrictions placed on the movement of animals, people
and other things to prevent the spread of disease.
National management
group (NMG)
A group established to direct and coordinate an animal
disease emergency. NMGs may include the chief executive
officers of the Australian Government and state or territory
governments where the emergency occurs, industry
representatives, the Australian CVO (and chief medical
officer, if applicable) and the chairman of Animal Health
Australia.
Native wildlife
See Wild animals
OIE Terrestrial Code
OIE Terrestrial Animal Health Code. Reviewed annually at
the OIE meeting in May and published on the internet at:
www.oie.int/international-standard-setting/terrestrialcode/access-online/
OIE Terrestrial Manual
OIE Manual of Diagnostic Tests and Vaccines for Terrestrial
Animals. Describes standards for laboratory diagnostic tests
and the production and control of biological products
(principally vaccines). The current edition is published on
the internet at:
www.oie.int/eng/normes/mmanual/a_summry.htm
Operational procedures
Detailed instructions for carrying out specific disease
control activities, such as disposal, destruction,
decontamination and valuation.
Sheep pox and goat pox (Version 3.1)
37
38. Filename: SGP3.1-18FINAL(12Aug11).doc
Owner
Premises
A tract of land including its buildings, or a separate farm
or facility that is maintained by a single set of services and
personnel.
Primary Industries
Ministerial Council
(PIMC)
The council of Australian national, state and territory and
New Zealand ministers of agriculture that sets Australian
and New Zealand agricultural policy (formerly the
Agriculture and Resource Management Council of
Australia and New Zealand).
See also Animal Health Committee
Quarantine
Legal restrictions imposed on a place or a tract of land by
the serving of a notice limiting access or egress of specified
animals, persons or things.
Restricted area
A relatively small declared area (compared with a control
area) around an infected premises that is subject to intense
surveillance and movement controls.
See Section 4 for further details
Risk enterprise
A defined livestock or related enterprise, which is
potentially a major source of infection for many other
premises. Includes intensive piggeries, feedlots, abattoirs,
knackeries, saleyards, calf scales, milk factories, tanneries,
skin sheds, game meat establishments, cold stores, artificial
insemination centres, veterinary laboratories and hospitals,
road and rail freight depots, showgrounds, field days,
weighbridges and garbage depots.
Sensitivity
The proportion of affected individuals in the tested
population that are correctly identified as positive by a
diagnostic test (true positive rate).
See also Specificity
Sentinel animal
Animal of known health status that is monitored to detect
the presence of a specific disease agent.
Seroconversion
The appearance in the blood serum of antibodies (as
determined by a serology test) following vaccination or
natural exposure to a disease agent.
Serosurveillance
Surveillance of an animal population by testing serum
samples for the presence of antibodies to disease agents.
Serotype
A subgroup of microorganisms identified by the antigens
carried (as determined by a serology test).
Serum neutralisation test
38
Person responsible for a premises (includes an agent of the
owner, such as a manager or other controlling officer).
A serological test to detect and measure the presence of
antibody in a sample. Antibody in serum is serially diluted
to detect the highest dilution that neutralises a standard
amount of antigen. The neutralising antibody titre is given
as the reciprocal of this dilution.
AUSVETPLAN Edition 3
39. Filename: SGP3.1-18FINAL(12Aug11).doc
Specificity
The proportion of nonaffected individuals in the tested
population that are correctly identified as negative by a
diagnostic test (true negative rate).
See also Sensitivity
Stamping out
Disease eradication strategy based on the quarantine and
slaughter of all susceptible animals that are infected or
exposed to the disease.
State or territory disease
control headquarters
The emergency operations centre that directs the disease
control operations to be undertaken in that state or
territory.
Surveillance
A systematic program of investigation designed to
establish the presence, extent or absence of a disease, or of
infection or contamination with the causative organism. It
includes the examination of animals for clinical signs,
antibodies or the causative organism.
Susceptible animals
Animals that can be infected with a particular disease.
Suspect animal
An animal that may have been exposed to an emergency
disease such that its quarantine and intensive surveillance,
but not pre-emptive slaughter, is warranted.
or
An animal not known to have been exposed to a disease
agent but showing clinical signs requiring differential
diagnosis.
Suspect premises
Temporary classification of a premises that contains a
susceptible animal(s) not known to have been exposed to
the disease agent but showing clinical signs that require
investigation(s).
See Section 4 for further details
Tracing
The process of locating animals, persons or other items that
may be implicated in the spread of disease, so that
appropriate action can be taken.
Vaccination
Inoculation of healthy individuals with weakened or
attenuated strains of disease-causing agents to provide
protection from disease.
– ring vaccination
Vaccination of susceptible animals around a focus of
infection to provide a buffer against the spread of disease.
Sheep pox and goat pox (Version 3.1)
39
40. Filename: SGP3.1-18FINAL(12Aug11).doc
Vaccine
Modified strains of disease-causing agents that, when
inoculated into an animal, stimulate an immune response
and provide protection from disease.
– attenuated
A vaccine prepared from infective or ‘live’ microbes that
have lost their virulence but have retained their ability to
induce protective immunity.
– inactivated
A vaccine prepared from a virus that has been inactivated
(‘killed’) by chemical or physical treatment.
Vector
A living organism (frequently an arthropod) that transmits
an infectious agent from one host to another. A biological
vector is one in which the infectious agent must develop or
multiply before becoming infective to a recipient host. A
mechanical vector is one that transmits an infectious agent
from one host to another but is not essential to the life cycle
of the agent.
Veterinary investigation
An investigation of the diagnosis, pathology and
epidemiology of the disease.
See also Epidemiological investigation
Wild animals
– native wildlife
– feral animals
Domestic animals that have become wild (eg cats, horses,
pigs).
– exotic fauna
Nondomestic animal species that are not indigenous to
Australia (eg foxes).
Zoning
The process of defining disease-free and infected areas in
accord with OIE guidelines, based on geopolitical
boundaries and surveillance, in order to facilitate trade.
Zoonosis
40
Animals that are indigenous to Australia and may be
susceptible to emergency animal diseases (eg bats, dingoes,
marsupials).
A disease of animals that can be transmitted to humans.
AUSVETPLAN Edition 3
41. Filename: SGP3.1-18FINAL(12Aug11).doc
Ab b r e vi a t i o n s
AAHL
Australian Animal Health Laboratory
AUSVETPLAN
Australian Veterinary Emergency Plan
CA
control area
CCEAD
Consultative Committee on Emergency Animal Diseases
CSIRO
Commonwealth Scientific and Industrial Research
Organisation
CVO
chief veterinary officer
DCP
dangerous contact premises
EAD
emergency animal disease
EDTA
ethylenediaminetetraacetic acid
ELISA
enzyme-linked immunosorbent assay
GPV
goat pox virus
IP
infected premises
LSD
lumpy skin disease
LSDV
lumpy skin disease virus
NMG
national management group
OIE
World Organisation for Animal Health
(formerly Office International des Epizooties)
PCR
polymerase chain reaction
PIHC
Primary Industries Health Committee
PIMC
Primary Industries Ministerial Council
RA
restricted area
SGP
sheep pox and goat pox
SP
suspect premises
SPV
sheep pox virus
Sheep pox and goat pox (Version 3.1)
41
42. Filename: SGP3.1-18FINAL(12Aug11).doc
References
Abo-Shehada MN (1990). Vaccine-induced goat pox in an imported saanen goat
flock in Jordan. Preventive Veterinary Medicine 9:159–191.
Abu-Elzein E, Housawi F, Ramadan O, Gameel A, Al-Afaleq A and Al-Gundi O
(2003). Observations on natural and experimental infection of sheep and goats
with a virulent field Capripoxvirus with a high affinity to goats. Veterinarski
Arhiv 73:119–131.
Agrawal SK and Soman JP (1997). Assessment of immune efficacy of attenuated
live goat pox vaccine against sheep pox and contagious ecthyma. Indian
Veterinary Journal 74(12):1016–1018.
Capstick PB (1961). Annual Report, Kenya Veterinary Department, Kenya, 45–47.
Coetzer JAW (ed) (2004). Lumpy Skin Disease, vol 2, Oxford University Press,
Oxford.
Davies FG (1976). Characteristics of a virus causing a pox disease of sheep and
goats in Kenya, with observations on the epidemiology and control. Journal of
Hygiene (Cambridge) 76:163–171.
Davies FG (1981). Sheep and goat pox. In: Virus Diseases of Food Animals, vol 2,
Gibbs EPJ (ed), Academic Press, London.
Davies FG (1991a). Lumpy skin disease of cattle: a growing problem in Africa and
the Near East. World Animal Review 68:37–42.
Davies FG (1991b). Lumpy skin disease, an African capripox virus disease of cattle.
British Veterinary Journal 147:489–503.
Davies FG (1991c). Lumpy Skin Disease, A Capripox Virus Infection of Cattle in Africa,
Food and Agriculture Organization of the United Nations, Rome.
Garner MG and Lack MB (1995). Modelling the potential impact of exotic diseases
on regional Australia. Australian Veterinary Journal 72(3):81–87.
Geering WA, Forman AJ and Nunn MJ (1995). Exotic Diseases of Animals: A Field
Guide for Australian Veterinarians, Bureau of Resource Sciences, Australian
Government Publishing Service, Canberra.
Hare WCD (1985). Diseases transmissible by semen and embryo techniques. OIE
Revue Scientifique et Technique, No. 4, OIE, Paris.
Hosamani M, Mondal B, Tembhurne PA, Bandyopadhyay SK, Singh RK and
Rasool TJ (2004). Differentiation of sheep pox and goat poxviruses by
sequence analysis and PCR–RFLP of P32 gene. Virus Genes 29:73–80.
Kitching RP (1986). Passive protection of sheep against capripox. Research in
Veterinary Science 41:247–250.
Kitching RP and Mellor PS (1986). Insect transmission of capripoxvirus. Research in
Veterinary Science 40:255–258.
Kitching RP and Taylor WP (1985). Transmission of capripox. Research in Veterinary
Science 39:196–199.
42
AUSVETPLAN Edition 3
43. Filename: SGP3.1-18FINAL(12Aug11).doc
Kitching RP, Hammond JM and Taylor WP (1986). A single vaccine for the control
of capripox infection in sheep and goats. Research in Veterinary Science
42:53–60.
NRC (National Research Council) (1993). Livestock, Committee on Managing Global
Genetic Resources: Agricultural Imperatives, Board on Agriculture, National
Research Council, National Academy Press, Washington DC, 222.
OIE (World Organisation for Animal Health) (2004). Manual of Diagnostic Tests and
Vaccines for Terrestrial Animals, 5th edition, OIE, Paris.
www.oie.int/eng/normes/mmanual/a_summry.htm
OIE (World Organisation for Animal Health). OIE Terrestrial Animal Health Code.
Reviewed annually at the OIE meeting in May and published on the internet
at: www.oie.int/international-standard-setting/terrestrial-code/accessonline/
Sawhney AN, Singh AK and Malik BS (1972). Goat pox; an anthropozoonosis.
Indian J Med Res 60:683–684.
Sheikh-Ali MA, Hamad ME, Ali BH and Ali AS (2004). Alterations in some
epidemiological patterns and virus heterogeneity recently observed in
sheeppox outbreaks in the Sudan. Veterinarski Arhiv 74:341–350.
Tulman ER, Alfonso CL, Lu Z, Zsak L, Sur J-H, Sandybaev NT, Kerembekova UZ,
Zaitsev VL, Kutish GF and Rock DL (2002). The genomes of sheeppox and
goatpox viruses. Journal of Virology 76:6054–6061.
von Bakos K and Brag S (1957). Untersuchungen über Ziegenpocken in Schweden.
Nord Vet-Med 9:431–449.
Williams S (2003). Persistence of disease agents in carcases and animal products.
Report for Animal Health Australia, 58–61.
Video/training resources
See the Summary Document for a full list of training resources.
Sheep pox and goat pox (Version 3.1)
43